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ABSTRACT 
 
EPIGENOMIC AND TRANSCRIPTIONAL REGULATION OF 
HEPATIC METABOLISM BY REV-ERB AND HDAC3 
 
Dan Feng 
Mitchell A. Lazar 
 
 
 
Metabolic activities are regulated by the circadian clock, and disruption of the clock 
exacerbates metabolic diseases including obesity and diabetes. Transcriptomic studies in 
metabolic organs suggested that the circadian clock drives the circadian expression of 
important metabolic genes. Here we show that histone deacetylase 3 (HDAC3) is 
recruited to the mouse liver genome in a circadian manner. Histone acetylation is 
inversely related to HDAC3 binding, and this rhythm is lost when HDAC3 is absent.  
Diurnal recruitment of HDAC3 corresponds to the expression pattern of REV-ERB, an 
important component of the circadian clock. REV-ERB colocalizes with HDAC3 near 
genes regulating lipid metabolism, and deletion of HDAC3 or Rev-erb in mouse liver 
causes hepatic steatosis. Thus, genomic recruitment of HDAC3 by REV-ERB directs a 
circadian rhythm of histone acetylation and gene expression required for normal hepatic 
lipid homeostasis. In addition, we reported that the REV-ERB paralog, REV-ERBalso 
displays circadian binding similar to that of REV-ERB. REV-ERB also recruits 
HDAC3 and protects the circadian clock and hepatic lipid homeostasis in the absence of 
REV-ERB REV-ERBs are indeed essential components of the circadian clock 
Furthermore, we discovered that REV-ERBs competes with ROR for genomic binding 
vi 
 
at Bmal1 and Npas2 genes, and drives a diurnal binding of ROR. We then identified 
thousands of competing sites by ROR ChIP-seq, many of which are in close proximity 
of clock and metabolic genes. We also discovered many ROR binding sites with no 
rhythmic ROR binding or rhythmic ROR binding in-phase with REV-ERBs. 
Collectively, these findings indicate that REV-ERBs, HDAC3 and potentially ROR 
mediate the epigenomic and transcriptional regulation of liver metabolism by the 
circadian clock.  
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General Introduction 
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1.1 Circadian Regulation of Metabolism 
The approximately 24 hour cycling of light and dark drives the cyclic changes in the 
living environments for most organisms on Earth, from cyanobacteria to human beings. 
To adapt to changing environments, organisms anticipate the periodic changes and adjust 
their activities with the time of the day using an internal 24 hour clock system, known as 
the circadian clock. In human beings and other mammals, the clock governs many 
important behaviors and physiological processes including sleep/wake, feeding, body 
temperature, hormone secretion and metabolism. 
 
Human beings are diurnal creatures. We conduct most of our activities during the day, 
including feeding, exercising and working, and rest at night. Circadian clocks in our 
bodies provide time cues for activities, and meanwhile synchronize the metabolic 
reactions with the anticipated activity cycles. The synchronization of behaviors and 
metabolism by the clock ensures the energy supply and maintains the internal 
homeostasis. However, this delicate system has been increasingly challenged in modern 
society. Modern life is characterized by increase in night activities, for instance, shift 
work, overtime work, night eating, sleep disruption and deprivation. Misalignment of 
activities with the internal clock and metabolic rhythms could disrupt the clock and 
energy homeostasis. Evidence suggests that shift workers have a higher risk of metabolic 
diseases, including obesity, diabetes, metabolic syndromes and cardiovascular diseases 
(Antunes et al., 2010; Wang et al., 2011). Similar effects were also observed with sleep 
deprivation, sleep disruption and night eating (Reviewed in Huang et al., 2011). In 
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recognition of these concerns, much recent research focuses on the crosstalk between the 
circadian clock and metabolism.  
 
1.1a The Molecular Clock System 
The cell-autonomous clock machinery consists of several transcriptional-translational 
feedback loops, which allows autonomous oscillation with a period of approximately 24 
hours (Figure 1.1). In mammals, the first feedback loop in the basic clock machinery 
contains a heterodimer of transcription activators the brain and muscle ARNTL-like 
protein 1 (BMAL1) and the circadian locomoter output cycles kaput (CLOCK). 
BMAL1/CLOCK activates transcription of Crytochromes (CRYs) and Periods (PERs). 
CRY and PER proteins negatively regulates their own expression by binding 
BMAL1/CLOCK and inhibiting their transcriptional activity (reviewed in Levi and 
Schibler, 2007). Another critical feedback loop drives the cyclic transcription of BMAL1 
using nuclear receptor (NR) REV-ERB/REV-ERB. BMAL1 activates Rev-erb 
transcription, which then suppresses Bmal1 transcription (Preitner et al., 2002). The clock 
machinery is featured by the redundancy of their components: BMAL1/BMAL2, 
CLOCK/NPAS2 (neuronal PAS domain containing protein 2), CRY1/CRY2, 
PER1/PER2/PER3, REV-ERB/REV-ERB(DeBruyne et al., 2007; van der Horst et al., 
1999; Shi et al., 2010; Zheng et al., 2001) (Figure 1.1). Other factors that are important 
for clock function include the Retinoid-related orphan receptor RORs (ROR, ROR, 
ROR), which activate transcription of BMAL1 and REV-ERB, and are repressed by 
REV-ERB(reviewed in Jetten, 2009). Levels of the clock proteins are also subject to 
posttranslational regulation by casein kinases (CKI and CKI), and ubiquitin E3 ligase 
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-TrCP, FBXL3 and ARF-BP1/PAM (Yin et al., 2010; reviewed in Gallego and Virshup, 
2007; Levi and Schibler, 2007).  
 
Although the transcriptional-translational clocks are ubiquitous in mammalian cells, non-
transcriptional mechanisms are aslo sufficient to sustain circadian oscillation. In pico-
eukaryotic alga Ostreococcus tauri, oxidation of peroxiredoxin proteins undergoes 
circadian cycles independent of its transcriptional circadian clock (O’Neill et al., 2011).  
Recently  this mechanism was shown to be conserved in higher organisms including 
human, at least in human red blood cells (O’Neill and Reddy, 2011). The wide-spread 
presence of transcription-independent redox oscillations suggests that crosstalk between 
metabolic cycles and circadian clocks has long played a significant role in both 
physiology and evolution. 
 
In mammals, the basic clock machinery is present in most organs, assembled in a 
hierarchical system in which the central clock can entrain peripheral clocks (Figure 1.2). 
The central clock is located in the suprachiasmatic nuclei (SCN) of the anterior 
hypothalamus, while peripheral clocks are present in most organs, including metabolic 
organs such as liver, adipose, heart, muscle and kidney (reviewed in Dibner et al., 2010; 
Welsh et al., 2010). Both the central clock and peripheral clocks can sense and respond to 
environmental changes, and keep synchronized with the environment. The environmental 
cues that can rest the clock are known as Zeitgebers (“time-giver”). The predominant 
Zeitgeber for the central clock is light, which is sensed by retina and signals directly to 
SCN. The central clock can then entrain the peripheral clocks through neuronal and 
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hormonal signals, as well as body temperature, aligning all clocks with the external 
light/dark cycle (Balsalobre et al., 2000; Brown et al., 2002; reviewed in Dibner et al., 
2010; Welsh et al., 2010). Peripheral clocks in metabolic tissues are also entrained by the 
central clock through feeding/fasting cycles (Figure 1.2). Fasting/feeding alters the levels 
of key endocrine hormones and the intracellular metabolic state, which can modulate the 
function of peripheral clocks. When restricted food availability shifts the fasting/feeding 
cycles, peripheral clocks can be reset separately from the central clock, suggesting that 
food availability is the predominant Zeitgeber for these clocks (Damiola et al., 2000; 
Stokkan et al., 2001).  
 
1.1b Circadian Oscillation of Metabolism 
Metabolic activities undergo diurnal changes, as reflected by the oscillating hormone 
levels in blood and rhythmic activities of metabolic pathways. Hormones mediate the 
crosstalk between the central nervous system and major metabolic organs, and are 
essential to metabolic homeostasis. Some of them are secreted in a circadian manner, 
including insulin and glucagon from pancreas, adiponectin and leptin from adipose, and 
ghrelin from stomach (reviewed in Froy, 2007). Many metabolic pathways display 
rhythmic activities, consistent with levels and activities of the rate-limiting enzymes. For 
instance, in liver, gluconeogenesis peaks in the daytime with PEPCK activity (Kida et al., 
1980), and cholesterol and bile acid synthesis peaks around midnight, same as HMG-
CoA reductase (HMGCR) activity (Back et al., 1969; Higgins et al., 1971). Rhythmic 
activities were also observed in xenobiotic metabolism, glycogen metabolism and amino 
6 
 
acid metabolism, and in other metabolic tissues, such as fat (reviewed in Davidson et al., 
2004; Gimble and Floyd, 2009).  
 
Transcriptomic studies in different metabolic organs and SCN revealed that a large 
proportion of the whole transcriptomes, from 3% to 20%, undergo circadian oscillation 
(Akhtar et al., 2002; Balsalobre et al., 1998; McCarthy et al., 2007; Panda et al., 2002; 
Storch et al., 2002; Ueda et al., 2002; Zvonic et al., 2006). The circadian transcriptomes 
are tissue-specific and tightly correlated with cellular functions, supporting that circadian 
clocks control metabolic activities through transcriptional regulation of key metabolic 
genes. In liver, it includes genes involved in glucose, lipid and xenobiotic metabolism; In 
skeletal muscle, it mostly contains genes involved in lipid metabolism; In the SCN, it 
includes genes involved in protein-neuropeptide synthesis, secretion and degradation and 
regulation of mouse locomoter activity (Akhtar et al., 2002; McCarthy et al., 2007; Panda 
et al., 2002). while Circadian control of activities can also be mediated through 
translational and post-translational regulation (Reddy et al., 2006).  
 
1.1c The Molecular Clock Controls Metabolic Activities 
The role of the circadian clock in metabolic regulation is well supported by genetic 
evidence that mutation in clock genes disturbs rhythmic expression of key metabolic 
genes and causes metabolic disorders. Key metabolic pathways under clock control will 
be discussed in this section. In addition, other metabolic or related pathways are also 
regulated by the circadian clock, including cardiovascular function and inflammation 
(reviewed in Bass and Takahashi, 2010).  
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Glucose homeostasis Loss of BMAL1 attenuates the diurnal variation in glucose and 
triglyceride levels, impairs gluconeogenesis and shows glucose intolerance, while the 
Clock mutant mice (Clock19) develop hyperglycemia and hypoinsulinemia (Lamia et 
al., 2008; Rudic et al., 2004; Turek et al., 2005). Both genetic models suggest that 
BMAL1/CLOCK plays a critical role in glucose homeostasis. The study was followed by 
tissue-specific deletion of Bmal1 in liver and pancreatic  cells, both of which support 
the critical role of peripheral clocks in metabolic tissues. Loss of BMAL1 in liver 
abolishes rhythmic expression of glucose metabolic genes, e.g. Pepck and Glut2, and 
leads to hypoglycemia only in the fasting phase of the day, while loss of BMAL1 in 
pancreatic  cells impairs insulin secretion (Lamia et al., 2008; Marcheva et al., 2010).  
 
Other clock components also play a role. CRYs inhibit gluconeogenic gene expression, 
probably through regulating CREB activity. Therefore, hepatic depletion of CRY1/2 
increases circulating glucose, while CRY1 overexpression reduces fasting blood glucose 
and improves whole body insulin sensitivity in db/db mice (Zhang et al., 2010). CRYs 
also transrepress glucocorticoid-induced Pepck transcription, and loss of CRYs results in 
glucose intolerance (Lamia et al., 2011). Similarly depletion of both REV-ERBs 
increases fasting blood glucose (Cho et al., 2012). And ROR is known to activate 
G6pase through SRC-2 and BAF60a (Chopra et al., 2008; Tao et al., 2011).   
 
Lipid metabolism Clock mutation and Bmal1 deficiency also impairs lipid metabolism, 
as shown by hyperleptinemia, hyperlipidemia and hepatic steatosis (Shimba et al., 2011; 
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Turek et al., 2005). The mechanism behind this remains unclear. REV-ERB agonists 
inhibit lipid and cholesterol synthesis in liver and fat, and promote fatty acid and glucose 
oxidation in muscle, resulting in increased energy expenditure. These agonists 
significantly improve dyslipidemia and hyperglycaemia in a diet-induced obesity model 
(Solt et al., 2012). In addition, BMAL1 and REV-ERB both regulates adipocyte 
differentiation (Laitinen et al., 2005; Shimba et al., 2005; Wang and Lazar, 2008).  
 
Bile acid metabolism REV-ERB is an important regulator of bile acid synthesis. 
Genetic ablation of REV-ERB lowers bile acid synthesis and decreases bile acid 
accumulation in the liver, correlated with altered phase and total decrease of Cyp7a1 
expression (Duez et al., 2008; Le Martelot et al., 2009). REV-ERBmay indirectly 
activates Cyp7a1 via E4bp4 and SHP, or via LXR (Duez et al., 2008; Le Martelot et al., 
2009). REV-ERB also regulates SREBP function through its regulator INSIG2 and thus 
the SREBP targets involved in cholesterol and lipid metabolism (Le Martelot et al., 2009). 
Loss of BMAL1 increases circulating cholesterol, and loss of PER1/2 up-regulates bile 
acid synthesis and results in hepatic cholestasis (Ma et al., 2009; Shimba et al., 2011). 
 
1.2 Clock and Epigenome 
1.2a Transcriptional Regulation by the Circadian Clock 
How does the circadian clock drive rhythmic gene expression in different tissues? In the 
core clock machinery, BMAL1/CLOCK, REV-ERBs, PERs, CRYs and RORs are all 
transcription regulators. BMAL1/CLOCK displays rhythmic genome binding and can 
drive the rhythmic expression of its targets (Rey et al., 2011; Ripperger and Schibler, 
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2006). REV-ERB directly regulates gluconeogenic enzymes G6pase and PEPCK (Yin 
et al., 2007). More importantly, the core clock machinery can drive circadian expression 
of many transcription factors, thus extending and enhancing its regulatory function. 
Among these factors are nuclear receptors (NRs), such as retinoic acid receptors (RARs), 
TRs, peroxisome proliferator-activated receptors (PPARs), GR and short heterodimer 
partner (SHP) (Yang et al., 2006). Other transcription factors include the three members 
of the Prolin Acidic Amino acid Rich (PAR) domain basic leucine zipper proteins 
albumin D-site binding protein (DBP), thyrotroph embryonic factor (TEF), and 
hepatocyte leukemia factor (HLF), and the related protein E4BP4. All four of these 
proteins bind to D-boxes, but while DBP, TEF, and HLF are activators, E4BP4 is a 
repressor. Many of these factors are direct targets of the clock. BMAL1 controls PPAR 
and DBP, and REV-ERBcontrols SHP and E4bp4 (Canaple et al., 2006; Duez et al., 
2008). The circadian clock also regulates stability and activity of these factors. PER2 
binding promotes ER degradation, regulates PPAR DNA binding, and co-activates 
PPAR-mediated transcription (Gery et al., 2007; Grimaldi et al., 2010; Schmutz et al., 
2010), while CRY binding represses GR (Lamia et al., 2011). The clock can also regulate 
these factors indirectly, for instance, through their ligands such as glucocorticoid for GR 
(Reddy et al., 2007). The clock signal can also be mediated by transcription coactivators 
PGC-1 and BAF60a, or through post-transcriptional regulation by microRNAs (Gatfield 
et al., 2009; Tao et al., 2011; Wu et al., 2009).  
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1.2b Clock Regulation of the Epigenome 
In addition to the linear genomic DNA sequences, information affecting the expression of 
individual genes can be encoded in the chromatin using mechanisms such as DNA 
methylation, histone modification and chromatin remodeling. This additional layer of 
gene regulation may be referred to as the epigenome. Epigenomic modification provides 
plasticity in gene expression and cellular functions in multi-cellular organisms, and 
allows reversible changes in response to changes in the their environment, including light, 
temperature, food availability and dietary composition which can affect many 
physiological processes, including development, aging, and metabolism (reviewed in 
Christensen and Marsit, 2011; Portela and Esteller, 2010).  
 
Transcription factors control gene transcription by facilitating recruitment and activation 
of the transcription machinery, or by altering epigenome to recreate a more favorable 
environment for transcription, or most of the time both (reviewed in Farnham, 2009).  
Accumulating evidence, summarized in this section, implicates the core clock genes as 
partners of chromatin modifying enzymes (Table 1.1).  
 
Histone acetylation Histone acetylation undergoes cyclic oscillation with the clock, as 
evident in mouse liver, not only at the promoters of the clock genes and but also in a 
genome-wide scale (Curtis et al., 2004; Etchegaray et al., 2003; Naruse et al., 2004; 
Ripperger and Schibler, 2006). Histone acetylation is controlled by a battle between 
HATs and HDACs, both of which have been shown to associate with the clock 
machinery and participate in clock-regulated rhythmic gene transcription.  
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The BMAL1/CLOCK or BMAL1/NPAS2 heterodimer recruits both HATs and HDACs. 
BMAL1 binds transcription coactivator p300 and possibly the CREB binding protein 
(CBP), while CLOCK and NPAS2 bind p300 and the CBP-associated factor (PCAF) 
(Curtis et al., 2004; Etchegaray et al., 2003; Takahata et al., 2000). All three coactivators 
have intrinsic HAT activity. In liver and heart, p300 exhibits a circadian association with 
CLOCK or NPAS2, correlating with increase in Per1 mRNA and histone H3 acetylation 
on the Per1 promoter (Curtis et al., 2004; Etchegaray et al., 2003). BMAL1/CLOCK also 
directly interacts with SIRT1, recruits SIRT1 to the Dbp gene in a timely manner, and 
drives rhythmic histone acetylation and gene transcription (Asher et al., 2008; Nakahata 
et al., 2008) (Figure 1.5). Moreover, CLOCK itself is a HAT, and its HAT activity is 
essential for the rhythmic acetylation at the Per1 promoter and the circadian expression of 
Per1 and Dbp (Doi et al., 2006).  
 
PER and CRY direct the negative feedback signal to BMAL1/CLOCK probably through 
attenuating their affinity for DNA (Figure 1.1) (Ripperger and Schibler, 2006). In 
addition, through interaction with BMAL1/CLOCK, CRY1 can recruit Sin3B corepressor 
and HDAC1/2 to the Per1 promoter, and repress Per1 transcription through histone 
deacetylation (Naruse et al., 2004). Similarly, PER2 recruit Sin3A corepressor and 
HDAC1 through the polypyrimidine tract–binding protein–associated splicing factor 
(PSF) to the Per1 promoter (Duong et al., 2011).  
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REV-ERBs and RORs are members of the NR family, a family known to employ 
multiple coactivator and corepressor complexes for chromatin modification. REV-ERB 
recruits nuclear receptor corepressor (NCoR) and HDAC3 to deacetylate histones and 
repress transcription (Yin and Lazar, 2005). RORs interact with both corepressors and 
coactivators (reviewed in Jetten, 2009), and the rhythmic binding of RORs to the Npas2 
promoter are positively correlated with DNA accessibility and histone acetylation 
(Takeda et al., 2011).  
 
Histone methylation Whereas histone acetylation is usually associated with 
transcriptional activation, methylation has a mixed effect on transcription, depending on 
the modification sites. CLOCK interacts with and recruits the mixed lineage leukemia 1 
(MLL1), a HMT that specifically promotes H3K4me3, an activation mark. MLL1 is 
required for circadian H3K4 methylation and H3 acetylation and for circadian gene 
expression (Katada and Sassone-Corsi, 2010). PER1 associates with WD repeat-
containing protein 5 (WDR5), and loss of WDR5 abolishes the circadian H3K4 and 
H3K9 methylation at the Rev-erb promoter (Brown et al., 2005). Interestingly, MLL1 
and WDR5 can be present in the same methyltransferase complex. BMAL1/CLOCK 
binds polycomb protein EZH2 and methylates H3K27 at the Per1 and Per2 promoters, 
which is essential for CRY-mediated transcriptional repression (Etchegaray et al., 2006). 
BMAL1/CLOCK also recruits JumonjiC and ARID domain-containing histone lysine 
demethylase 1a (JARID1a) to the Per2 promoter, though it appears that the circadian 
functions of JARID1a may be independent of its histone modifying activity (DiTacchio et 
al., 2011).  
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Chromatin Remodeling Chromatin remodeling often accompanies histone modification 
and transcriptional regulation (reviewed in Strahl and Allis, 2000). One study showed 
that RORs recruit the  SWItch/Sucrose Non-Fermentable (SWI/SNF) chromatin 
remodeling complex subunit BAF60a to drive rhythmic Bmal1 and G6pase expression 
(Tao et al., 2011).  However, this aspect of clock function is understudied at the present 
time. 
 
Rhythmic chromatin modification is not limited to the promoter of clock genes that have 
been studied, as ChIP-seq revealed that BMAL1 binds thousands of sites throughout the 
genome (Dufour et al., 2011; Rey et al., 2011). In addition, the clock can drive rhythmic 
epigenomic programming indirectly through clock-regulated transcription factors, such as 
NRs, which then recruit HATs and HDACs.  
 
Non-histone targets of clock-associated histone modifiers Histone modifying enzymes 
also target transcription factors, cofactors and enzymes. CLOCK acetylates its partner 
BMAL1, and facilitates CRY1 binding and CRY1-mediated transcriptional repression 
(Hirayama et al., 2007). CLOCK also acetylates GR, attenuates its DNA binding, and 
regulates glucocorticoid response (Charmandari et al., 2011; Nader et al., 2009). SIRT1 
counteracts CLOCK-mediated BMAL1 acetylation, deacetylates and degrades PER2 thus 
derepressing BMAL1/CLOCK (Asher et al., 2008; Nakahata et al., 2008) (Figure 1.5). 
Activation or inhibition of transcription activity will also alter the epigenomic state of the 
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target genes. Also clock-associated histone modifiers can be recruited by other 
transcription factors and function independent of the clock machinery.  
 
1.3 REV-ERB Is an Orphan Nuclear Receptor 
1.3a Nuclear Receptor 
REV-ERB is a member of the nuclear receptor superfamily. Nuclear receptors are a 
large family of transcription factors that regulate differentiation, development and 
metabolic homeostasis in animals (reviewed in Bain et al., 2007). Classical nuclear 
receptors are ligand activated, and mediate the effects of important hormones, such as 
estrogen, glucocorticoid and thyroid hormone.  
 
Structure of nuclear receptors All members of the nuclear receptor superfamily share a 
similar structure. From N-terminal to C-terminal, a nuclear receptor can be divided into 
four domains: the N-terminal A/B domain, the DNA binding domain (DBD), the hinge 
region and the ligand binding domain (LBD) (reviewed in Bain et al., 2007). Both DBD 
and LBD are conserved among the family. Crystal structures show that LBD is a globular 
domain made up of approximately 12 -helices (reviewed in Li et al., 2003). LBD 
contains a hydrophobic ligand binding pocket and a ligand-regulated transcriptional 
activation function 2 (AF-2). AF-2 consists of Helix 12 and several other helices, and 
provides a hydrophobic groove that interacts with transcription coactivators (Bledsoe et 
al., 2002; Shiau et al., 1998). In addition, LBD is required for dimerization of nuclear 
receptors. DBD, as indicted by its name, recognizes and binds specific DNA sequences, 
known as the response elements. The core response element is usually a hexanucleotide 
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sequence, known as the half site. DBD is connected to LBD through the hinge region. 
The N-terminal A/B domain contains another transcriptional activation function termed 
as AF-1, and has weak conservation in the family. The variable N-terminal confers 
specificity to the functions of different nuclear receptors (Figure 1.3). 
 
Classification of nuclear receptors The nuclear receptor superfamily is usually divided 
into three different classes, based on their ligands and DNA binding properties (reviewed 
in Bain et al., 2007). The first class is steroid receptors, including androgen receptor (AR), 
estrogen receptor (ER) and glucocorticoid receptor (GR). In the presence of the ligand, 
steroid receptors dissociate from heatshock proteins, translocate to the nucleus from 
cytosol, and bind the palindromic half sites as a homodimer. The second class is the 
thyroid/retinoid receptor family, including thyroid receptor (TR) and retinoic acid 
receptor (RAR). Unlike the first class, the thyroid/retinoid receptor family stays on the 
genome, and ligand binding induces conformational changes in Helix 12, allowing the 
interaction with coactivators. They also have different dimerization patterns, and many of 
them form heterodimer with retinoid X receptor (RXR). Moreover, their response 
elements contain direct repeats of the half sites instead of palindromic sequences. The last 
class is known as the orphan nuclear receptor, which contains REV-ERB, its 
mammalian paralog REV-ERB and the RAR-related orphan receptors (RORs). Most 
nuclear receptors in this class have no known cognate ligands, and they were identified 
based on sequence homology to known nuclear receptors. Recent studies identified the 
ligands of some of these orphan nuclear receptors, such as bile acids for farnesoid X 
receptor (FXR) and fatty acids for peroxisome proliferator-activated receptors (PPARs). 
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These receptors are thus considered adopted orphan receptors (reviewed in Sonoda et al., 
2008).  
 
Coregulators of nuclear receptors Nuclear receptors regulate transcription through 
recruiting coactivator and corepressor complexes. Coactivator complexes usually contain 
histone acetyltransferases (HATs), such as p300 and CBP, and chromatin remodeling 
enzymes, such as BRG1, which create an epigenomic environment that favors gene 
transcription. Coactivators also help recruit RNA polymerase complex, and directly 
promote transcription (reviewed in Hermanson et al., 2002). Corepressor complexes 
usually contain histone deacetylases (HDACs), such as HDAC3 in the nuclear receptor 
corepressor (NCoR) complex and HDAC1/2 in the nucleosome remodeling and 
deacetylation (NURD) complex (reviewed in Perissi et al., 2010). In addition, corepressor 
complexes also contain chromatin remodelers, histone methyltransferases and 
demethylases.  
 
1.3b REV-ERB  
REV-ERB was one of the first orphan nuclear receptor to be discovered (Lazar et al., 
1989; Miyajima et al., 1988). Later, a highly related nuclear receptor REV-ERB was 
discovered, as well as a non-mammalian homologue E75, which is present in Drosophila 
and C. elegans (Bonnelye et al., 1994; Dumas et al., 1994; Retnakaran et al., 1994; 
Segraves and Hogness, 1990). Rev-erb is highly expressed in fat, muscle and brain, and 
regulates development in these tissues (Chawla and Lazar, 1993; Chomez et al., 2000; 
Downes et al., 1995).  
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REV-ERB isoforms REV-ERB has multiple isoforms. In human and rat, there are two 
different isoforms of Rev-erb mRNA, transcribed from different promoters. The protein 
products of these two isoforms differ in their N-terminal domain (Triqueneaux et al., 
2004). The longer isoform, REV-ERB1, is 614 amino acids long. The shorter isoform 
REV-ERB2, with N-terminal encoded in a different first exon, is 106 amino acid shorter. 
The importance of having two different isoforms remains unclear (Adelmant et al., 1996; 
Chopin-Delannoy et al., 2003).  
 
REV-ERB is a transcription repressor REV-ERB recognizes the classical nuclear 
receptor half site, a hexanucleotide AGGTCA sequence. Unlike many nuclear receptors, 
REV-ERBdoes not dimerize with RXR. It can bind the half site preceded by an AT-
rich sequence at the 5’ end as a monomer, or a direct repeat of the half sites separated by 
two nucleotides, known as the DR2 element as a homodimer (Harding and Lazar, 1993). 
Alternatively, two REV-ERB can bind independently at two half sites spaced apart, and 
collaboratively mediate transcriptional repression, as demonstrated in the promoter of the 
Bmal1 gene (Yin and Lazar, 2005).  
 
REV-ERB lacks Helix 12, which is responsible for coactivator recruitment. In 
consistent with its structure, it primarily functions as a transcription repressor by 
recruiting the NCoR corepressor complex. REV-ERB interacts with NCoR through the 
CoRNR motif located on the N-terminal of NCoR, and it prefers NCoR over other 
corepressors, including the closely related SMRT (silencing mediator of retinoic acid and 
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thyroid hormone receptor) (Hu et al., 2001; Ishizuka and Lazar, 2003). Importantly, 
REV-ERB interacts with NCoR with a stoichiometry of two REV-ERBs to one NCoR, 
as determined by steric preference of their binding interface (Zamir et al., 1997). 
Therefore, REV-ERB can only recruit NCoR and conduct active repression when two 
REV-ERBs bind two half sites as a homodimer. When REV-ERB binds as a monomer, 
it may repress transcription passively by competing with transcription activators, such as 
nuclear receptor RORs (Figure 1.4).   
 
The transcription repression activity of NCoR derives from its ability to directly interact 
with and inhibit the basic transcriptional machinery and its ability to recruit and activate 
histone deacetylase (HDAC) (reviewed in Hu and Lazar, 2000). Although NCoR has 
been shown to interact with many HDACs, its deacetylase activity mainly depends on 
HDAC3, which we will discuss later (Guenther et al., 2000; Ishizuka and Lazar, 2003; Li 
et al., 2000; reviewed in Lazar, 2003). Thus HDAC3 is required for transcription 
repression by nuclear receptors, such as TR and REV-ERB (Ishizuka and Lazar, 2003).  
Remarkably, the enzyme activity of HDAC3 requires NCoR, which interacts with 
HDAC3 through its deacetylase activation domain (DAD) (Guenther et al., 2001).   
 
REV-ERB is a member of the core clock machinery REV-ERB was identified as a 
major regulator of the cyclic expression of Bmal1, which is an essential component of the 
basic clock machinery. Two REV-ERB half sites were found in the promoter of Bmal1, 
and REV-ERB binding to the Bmal1 promoter is inversely correlated with Bmal1 
expression in a 24h cycle. Genetic ablation of Rev-erb severely blunted the circadian 
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expression of Bmal1, and significantly shortens the circadian period. REV-ERB was 
also shown to repress other clock genes, Clock, Cry1 and Per2, and was long known to be 
self-regulated (Adelmant et al., 1996; Preitner et al., 2002; Ueda et al., 2002). As a major 
repressor of Bmal1, REV-ERB is transcriptionally activated by BMAL1/CLOCK, 
forming a negative feedback loop that drives the circadian expression of both Rev-erb 
and Bmal1 (Triqueneaux et al., 2004).  
 
The role of REV-ERB in the circadian clock has long been considered auxiliary due to 
the generally intact circadian rhythm in Rev-erb deficient mice (Preitner et al., 2002). 
However, the basic clock machinery is featured by the redundancy of its components: 
Bmal1/Bmal2, Clock/Npas2, Per1/Per2/Per3 and Cry1/2. Except for Bmal1, the loss of 
any single component can be compensated by the remaining ones, and the circadian 
rhythm is largely preserved (Dallmann et al., 2011; van der Horst et al., 1999; Shi et al., 
2010; Zheng et al., 2001). Similar to other clock components, REV-ERB has a twin 
brother, REV-ERB, whose role in circadian rhythms remains unclear. It has been 
suspected that REV-ERB compensates for the loss of REV-ERB, and the role of both 
REV-ERBs in circadian clocks deserve a careful look.  
 
REV-ERB links the circadian clock and metabolism In addition to its role in circadian 
clock, REV-ERB also emerged as an important regulator of several metabolic pathways, 
including lipid and cholesterol metabolism. REV-ERB represses apolipoprotein ApoA-I 
and ApoC-III, and genetic ablation of Rev-erb leads increased plasma triglycerides and 
TG-rich very low density lipoprotein (VLDL) particles in mouse (Raspé et al., 2002; Vu-
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Dac et al., 1998). REV-ERB may also regulate fatty acid synthesis through the very 
long chain fatty acid elongase Elovl3 and peroxisome -oxidation through enoyl-CoA 
hydratase/3-hydroxyacyl-CoA dehydrogenase (HD) (Anzulovich et al., 2006; Kassam et 
al., 1999). As discussed in Session 1.1c, REV-ERB also regulates bile acid synthesis 
and adipocyte differentiation. As a result of these findings, REV-ERB is believed to be 
part of the missing link between the circadian clock and the circadian metabolic activities.  
 
Post-translational regulation of REV-ERB REV-ERB can be phosphorylated by 
GSK3 at its N-terminal, and phosphorylation protects REV-ERB from ubiquitin-
mediated degradation by ARF-BP1 and PAM. Lithium is a potent inhibitor of GSK3 
activity, and thus promotes REV-ERB degradation and activates Bmal1transcription 
(Yin et al., 2006, 2010). Originally categorized as an orphan receptor, REV-ERB was 
recently shown to bind heme. Heme can enhance NCoR recruitment and transcription 
repression by REV-ERB (Yin et al., 2007). The significance of this regulation will be 
discussed later.  
 
1.4 Metabolic Feedback to the Clock 
The circadian clock is regulated by metabolic signals such as fasting/feeding and dietary 
factors. Fasting and refeeding regulates the clock gene expression in peripheral tissues, 
particularly liver (Kawamoto et al., 2006; Tahara et al., 2011). High fat diet (HFD) 
lengthens the circadian period and attenuates clock oscillation (Kohsaka et al., 2007). 
Clock-associated histone modifiers such as p300 and SIRT1 are also regulated. Fasting 
decreases p300 phosphorylation and activates p300, and induces Sirt1 expression, while 
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high fat diet (HFD) inhibits p300 phosphorylation, lengthens the circadian period and 
attenuates clock oscillation (Liu et al., 2008b; Rodgers et al., 2005). The impact of 
metabolism might be mediated through hormones, such as glucagon and insulin (Liu et 
al., 2008b; Tahara et al., 2011), as well as metabolites. The circadian clock can sense the 
intracellular metabolite levels, adjust its own rhythm and functions and allows a fine and 
precise temporal regulation of metabolic pathways within individual cells. We will focus 
on the key metabolites such as NAD
+
, AMP and heme, though other metabolites may 
also play a role.  
 
NAD
+
/NADH NAD
+
/NADH redox equilibrium indicates the metabolic state of the cell. 
NADH and NADPH directly binds CLOCK or NPAS2 and enhances BMAL1/CLOCK 
(or NPAS2) DNA binding, while the reduced form NAD
+
 binds and inhibits (Rutter et al., 
2001). NAD
+
/NADH ratio also regulate SIRT1, which deacetylates PER2, BMAL1 and 
histones (Asher et al., 2008; Nakahata et al., 2008) (Figure 1.5). Intracelluar NAD
+
 levels 
are circadian, and are critical for circadian clock functions (Sahar et al., 2011).  
 
NAD
+
 levels are determined both by the fasting/feeding cycles and circadian rhythms. 
Fasting induces NAD
+
 levels in liver, as well as SIRT1 protein levels (Rodgers et al., 
2005). Circadian clocks regulates NAD
+
 mainly through the NAD
+
 salvage pathway, in 
which NAD
+
 is synthesized from nicotinamide (NAM), the byproduct of sirtuins, through 
the rate-limiting enzyme nicotinamide phosphoribosyltransferase (NAMPT). 
BMAL1/CLOCK drives the circadian expression of NAMPT and contributes to the 
rhythmic NAD
+ 
levels. NAD
+
 activates while NAM represses SIRT1, which interacts 
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with BMAL1/CLOCK and inhibits NAMPT transcription. Therefore, NAD
+
 drives a 
negative feedback on its own synthesis through SIRT1 and the circadian clock, and 
through NAD
+
, the intracellular metabolic state can regulate the clock (Figure 1.5) 
(Nakahata et al., 2009; Ramsey et al., 2009).    
 
NAD
+
 is also a substrate of poly(ADP-ribose) polymerase 1 (PARP-1), an NAD
+
-
dependent ADP-ribosyltransferase. PARP-1 activity oscillates in a daily manner, and is 
regulated by feeding. PARP-1 binds and poly(ADP-ribosyl)ates clock at the onset of the 
light phase, regulates BMAL1/CLOCK interaction with PER and CRY and 
BMAL1/CLOCK DNA binding, and mediates food entrainment of the liver clock. NAD
+
 
might play a role in regulating PARP-1 activity by feeding, but other mechanisms are 
also involved (Asher et al., 2010).  
  
AMP/ADP AMP and ADP bind AMPK, inhibit AMPK dephosphorylation and activate 
its kinase activity. Therefore, AMPK functions as a sensor of energy state in the cell, 
which is reflected by AMP and ADP levels (Cantó and Auwerx, 2011). Several studies 
place AMPK as a circadian clock regulator (Lamia et al., 2009; Um et al., 2007, 2011; 
Vieira et al., 2008) with two different mechanisms: AMPK activates CKI and promotes 
PER2 degradation(Um et al., 2007); AMPK phosphorylates Cry1 and destabilizes it 
(Lamia et al., 2009) (Figure 1.5). AMPK also regulates the NAD
+
/NADH ratio, through 
which it crosstalks with SIRT1 (Cantó et al., 2009). 
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Heme As we discussed earlier, heme is a ligand of REV-ERB and REV-ERB, and 
enhances corepressor recruitment and transcriptional repression (Pardee et al., 2009; 
Phelan et al., 2010; Raghuram et al., 2007; Yin et al., 2007) (Figure 1.5). Through heme, 
REV-ERBs can sense the redox state and gas such as O2, NO and CO, as they regulate 
REV-ERB structure and corepressor recruitment (Pardee et al., 2009). Also heme binding 
can be regulated by the redox state of the REV-ERB protein (Gupta and Ragsdale, 
2011). Heme is also a component of NPAS2, whose heterodimeric DNA binding with 
Bmal1 is inhibited by CO (Dioum et al., 2002; Gilles-Gonzalez and Gonzalez, 2004).  
 
Like NAD
+
, heme can also negatively regulate its own synthesis through the circadian 
clock. The control is exerted on the expression of the rate-limiting enzyme in heme 
biosynthesis, -aminolevulinate synthase (ALAS1), whose expression is circadian. Heme 
inhibits BMAL1/NPAS2-activated ALAS1 expression and heme biosynthesis (Kaasik 
and Lee, 2004). In parallel, through REV-ERB, heme represses PGC-1 transcription, a 
potent inducer of heme biosynthesis (Wu et al., 2009) (Figure 1.5). Both NAD
+
 and heme 
are critical metabolites and indicators/sensors of the metabolic state in the cells. The 
negative metabolite feedback loops connect metabolism with the circadian clock, and are 
critical for metabolic homeostasis and fine tuning of the clock function.  
 
1.5 Rhythmic Regulation of Metabolism by Food Intake 
A key unanswered question is whether the rhythmic feature of metabolism is a passive 
response to the fasting/feeding cycles in metabolic tissues or an active anticipatory 
mechanism directly governed by the circadian clock. Recent transcriptomic studies in 
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mouse liver provide some insight. Liver-specific overexpression of REV-ERBabolishes 
oscillation of almost all the rhythmic transcripts found in wildtype mice, suggesting that 
they are controlled by the liver clock (Kornmann et al., 2007). Meanwhile, only a small 
subset of these transcripts, including the clock genes, maintain their oscillation under 
fasting, suggesting most of the rhythmic transcripts are also regulated by fasting/feeding. 
Interestingly, in clock deficient mice restricted feeding can resume oscillation of about 60% 
of the rhythmic transcripts and even increase their amplitude, along with many other non-
rhythmic genes (Vollmers et al., 2009). These observations suggest that under normal 
conditions, peripheral clocks and fasting/feeding cycles work together to drive rhythmic 
gene expression and metabolic activities.  
 
Fasting/feeding activities are usually aligned with sleep/wake cycles, and are timed by 
the central clock. Therefore, normally both the central clock and peripheral clocks 
synergize in rhythmic metabolic regulation. In addition to feeding/fasting, the central 
clock can also drive metabolic activities through hormones and body temperature (Brown 
et al., 2002; Reddy et al., 2007). For instance, blood glucocorticoid levels exhibits 
circadian oscillation (Oster et al., 2006). In the absence of the central clock, daily 
glucocorticoid injection can restore about 60% of the liver circadian transcriptome, 
probably through hepatocyte nuclear factor 4 (HNF4) (Maywood et al., 2007; Reddy 
et al., 2007). Therefore, under normal conditions, the central clock synchronize peripheral 
clocks, fasting/feeding cycles, hormone secretion and body temperature changes, and all 
of these contribute to the rhythmic metabolic activities throughout the body (Figure 1.2).  
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On the other hand, fasting/feeding is also subject to food availability in the environment, 
and changes in metabolic profiles as induced by fasting/feeding can impact and even 
reset the peripheral clocks in metabolic tissues.  Thus, in addition to the clock regulating 
metabolism, metabolism can regulate the clock.  
 
1.6 Hypothesis and Objectives 
In mammals, metabolic processes in peripheral organs display robust circadian rhythms, 
coordinated with the daily cycles of light and nutrient availability. Circadian 
misalignment causes metabolic dysfunction, and people engaged in night-shift work 
suffer from higher incidences of obesity, diabetes, and metabolic syndrome. 
Transcriptomics evidence suggests that circadian control of metabolism is achieved 
through transcriptional and probably epigenomic regulation of metabolic genes. In this 
dissertation, we explore the role of histone deacetylase HDAC3, an epigenomic modifier, 
in the circadian regulation of hepatic metabolism. First we hypothesize that HDAC3 
displays circadian genomic binding in mouse liver, and drives rhythmic histone 
acetylation and thus oscillation of important metabolic genes. HDAC3 is thus critical for 
metabolic homeostasis in liver. To address this hypothesis, in Chapter 3, we profile 
HDAC3 binding and histone acetylation in mouse liver genome at different times of the 
day, and reveal the role of REV-ERB in regulating HDAC3 genomic binding. Next, we 
hypothesize that other nuclear receptors, particularly the highly related REV-ERB and 
RORs, also play an important role in the circadian regulation of hepatic metabolism. In 
Chapter 4, we examine how these nuclear receptors work with REV-ERB and HDAC3 
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in regulating circadian rhythms and metabolism. Chapter 5 summarizes the work and 
discussed the future directions.   
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Figure 1.1 The Core Machinery in Mammals. The core clock machinery consists of 
two transcriptional-translational feedback loops. In the first loop, BMAL1/ClOCK 
activates transcription of Per and Cry, whose proteins bind and repress BMAL1/CLOCK 
activity. A second loop, once considered auxiliary, controls Bmal1 expression; 
BMAL1/CLOCK activates Rev-erb and Rev-erb transcription, and REV-ERB proteins 
repress Bmal1 transcription. The core clock proteins are also subject to post-translational 
regulation by AMPK, CKI/, rCP1/FBXL3 and ARF-BP1/PAM. BMAL1/CLOCK 
and REV-ERBs also control the expression of output genes, driving circadian rhythms in 
metabolism, feeding, locomotor activity and others.  
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Figure 1.2 Assembly of the Circadian Clocks in Mammals. The circadian clocks in 
mammals are assembled in a hierarchical manner. The central clock, located in the SCN 
in hypothalamus, regulates and synchronizes the peripheral clocks located in many 
metabolic organs including liver through neuronal and hormonal signals (Grey arrow). 
However, the predominant Zeitgeber for the liver clock is food intake, which regulates 
the liver clock and metabolic rhythms through hormonal and nutritional signals. When 
restricted food availability shifts the fasting/feeding cycles, peripheral clocks can be reset 
separately from the central clock. 
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Figure 1.3 Schematic Structure of Nuclear Receptor. A typical nuclear receptor can be 
divided into four domains: the N-terminal A/B domain, the DNA binding domain (DBD), 
the hinge region (H) and the ligand binding domain (LBD). The LBD binding domain 
contains activation function 2 (AF-2), which mediates coactivator recruitment and 
transcriptional activation. The A/B domain contains activation function 1 (AF-1).  
  
A/B 
                   AF-1 
DBD  H LBD 
AF-2  
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Figure 1.4 REV-ERB-Mediated Transcription Repression.  
A. REV-ERB binds as a monomer at a nuclear receptor half site (AGGTCA) preceded 
by an A/T-rich sequence, and does not recruit corepressors.  
B. REV-ERB binds as a homodimer at the DR2 element (direct repeat of half sites 
separated by 2 nucleotides) and recruits the NCoR corepressor complex and HDAC3.  
C. REV-ERB binds independently at two half sites spaced apart, but cooperatively 
recruits the NCoR corepressor complex and HDAC3.  
A 
B 
C 
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Figure 1.5 Metabolite Regulation of the Clock. BMAL1/CLOCK and REV-ERBs drive 
rhythmic metabolic outputs, including NAD
+
 and heme biosynthesis, while intracellular 
NAD
+
 and heme feedback on the clock through their sensors, SIRT1 and REV-ERBs, 
respectively. Intracelluar AMP levels regulates the circadian clock through activation of 
AMPK and degradation of PER and CRY. The core clock also drives many metabolic 
pathways in different tissues, which also contribute to the intracellular metabolite pool 
and metabolic state. 
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Table 1.1 Clock-associated Chromatin Modifying Activities 
Clock 
Component 
Associated 
Chromatin 
Modifier 
Targets References 
BMAL1 
/CLOCK 
Clock H3K9, H3K14 
Bmal1(K537), 
GR 
(Doi et al., 2006;  
Nader et al., 2009; 
Charmandari et al., 2011) 
p300 H3  (Etchegaray et al., 2002; 
Takahata et al., 2000) 
PCAF  (Curtis et al., 2004) 
CBP  (Takahata et al., 2000;  
Curtis et al., 2004) 
SIRT1 H3K9, H3K14, 
Bmal1(K537), 
Per2 
(Asher et al., 2008;  
Nakahata et al., 2008) 
MLL1 H3K4 (Katada and Sassone-
Corsi, 2010) 
EZH2 H3K27 (Etchegaray et al., 2006) 
JARID1a  (DiTacchio et al., 2011) 
BMAL1 
/NPAS2 
p300 H3, H4 (Curtis et al., 2004) 
PCAF H3, H4 (Curtis et al., 2004) 
ACTR  (Curtis et al., 2004) 
PER PSF-Sin3A-
HDAC1 
H3, H3K9, 
H4K5 
(Duong et al., 2011) 
WDR5 H3K4 (Brown et al., 2005) 
CRY Sin3B-HDAC1/2 Histone H3, H4 (Naruse et al., 2004) 
REV-ERB NCoR-HDAC3 H3, H4, H3K9 (Ishizuka and Lazar, 2003; 
Yin and Lazar, 2005;  
Feng et al, 2011;  
Bugge et al, 2012) 
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Chapter 2 
Material and Methods 
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Animals   
WT C57Bl/6 mice were purchased from Jackson Labs. The Rev-erbα knockout mice 
were obtained from B. Vennström, and backcrossed ≥7 generations with C57/Bl6 mice.  
The HDAC3
fl/fl
 mice were produced from C57Bl/6 embryonic stem cells with loxP sites 
flanking exon 4 to exon 7, which encode the catalytic domain of HDAC3 (Mullican et al., 
2011). The HDAC3
fl/fl
 mice were then crossed with Alb-Cre mice to generate 
HDAC3
fl/fl
/Alb-Cre mice. The ROR sg/sg mice was purchased from Jackson Labs.  
 
8 to 12 week old WT and mutant male mice were housed under the 12h-light/12h-dark 
(LD) cycles (lights on at 7 AM, lights off at 7 PM) for at least 2 weeks, and euthanized at 
ZT10 (5 PM) or ZT22 (5 AM). For constant darkness, light remained off after 12h 
darkness, and mice were euthanized either 10h later (CT10) or 22h later (CT22). For 
restricted feeding, mice were kept in LD cycles for 2 weeks with food available only 
between ZT3 and ZT11, and euthanized in constant darkness at CT10 or CT22. All the 
animal care and use procedures followed the guidelines of the Institutional Animal Care 
and Use Committee of the University of Pennsylvania.  
 
Liver tissues from the chronic jet-lag mice and the Cry DKO mice were a gift from Dr. 
Loning Fu at the Baylor College of Medicine.  
 
Synchronized MEFs 
MEFs were collected at embryonic day 13.5 from wild-type or Rev-erbα-null embryos, 
expanded, and seeded in 24-well plates at a density of 5 × 10
4
 cells per well. The MEFs 
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were washed in PBS and incubated for 20 h with 5.7 × 10
9
 particles (GC) of adenovirus 
per well in DMEM containing 0.5% bovine serum. Serum shock was performed by 
replacing starvation medium with 50% horse serum for 2 h. Following two washes in 
PBS, cells were changed back to DMEM containing 0.5% bovine serum, and total RNA 
was harvested at the indicated time points. 
 
Antibodies and reagents   
HDAC3 antibodies were purchased from Abcam (ab7030, for ChIP-Seq and western blot) 
and Santa Cruz (sc-11417, for validation). REV-ERBα antibody was purchased from Cell 
Signaling Technology (#2124). REV-ERBβ antibody was raised in a rabbit against amino 
acids 243–261 (Covance). Acetylated H3K9 antibody was purchased from Millipore 
(#07-352). Two ROR antibodies were purchased from Santa Cruz: C-16 (sc-6062) for 
ChIP-seq and H-65 (sc-28612) for validation. p300 antibody was purchased from Santa 
Cruz (sc-585).  
 
Constructs and gene transductions 
The adeno-associated viruses encoding Cre recombinase (AAV-Cre) and GFP (AAV-
GFP) were obtained from the Vector Core of the Penn Diabetes and Endocrinology 
Research Center. The Cre or GFP gene was inserted into the AAV2/8 vector containing 
the liver specific Tbg promoter (Gao et al., 2002). Each 12 week old male HDAC3
fl/fl 
mouse received 1.5 ×10
11
 particles of virus through tail-vein injection. The adeno-
associated virus encoding mouse ROR4 was constructed using the same AAV2/8 vector 
containing Tbg promoter as AAV-GFP. The virus was packaged by the Vector Core of 
36 
 
the Penn Diabetes Research Center. Each mice received 4 × 10
11
 particles (GC) of virus 
through tail vein injection. The adenoviruses encoding shRNA targeting the β-
galactosidase (TGCACCTGGTAAATCTTAT) or the Rev-erbβ gene 
(GCACTAAGGACCTTAATAATG) were constructed using the BLOCK-iT adenoviral 
RNAi expression system from Invitrogen (#K4941-00) and subsequently amplified and 
purified by the Vector Core of the Penn Diabetes Research Center. Each mouse received 
5.7 × 10
11
 particles (GC) of virus through tail vein injection.  
 
Chromatin Immunoprecipitation (ChIP) 
Mouse liver was harvested immediately after euthanasia. It was quickly minced and 
cross-linked in 1% Formaldehyde for 20 min, followed by quenching with 1/20 volume 
of 2.5 M glycine solution, and two washes with 1× PBS. Nuclear extracts were prepared 
by Dounce homogenization in cell lysis buffer (5mM PIPES, 85mM KCl, 0.5% Igepal 
and complete protease inhibitor tablet from Roche, pH8.0). Chromatin fragmentation was 
performed by sonication in ChIP SDS lysis buffer (50 mM HEPES, 1% SDS, 10 mM 
EDTA, pH7.5), using the Bioruptor (Diagenode) for the HDAC3, Rev-erbα and RNA Pol 
II ChIP, or by MNase (Sigma) digestion (6U/ml for 20 minutes) in MNase digestion 
buffer (20mM HEPES, 100mM NaCl, 1.5mM CaCl2, 3mM MgCl2 and 1mM PMSF, 
pH7.5) for H3K9 acetylation. Alternative: Frozen mouse liver was ground in liquid 
nitrogen, and cross-linked; After wash, the cross-linked liver was directly sonicated in 
ChIP dilution buffer (50 mM HEPES, 155 mM NaCl, 1.1% Triton X-100, 0.11% Na-
deoxycholate, 0.1% SDS, and complete protease inhibitor tablet, pH7.5). Proteins were 
immunoprecipitated in ChIP dilution buffer using different antibodies. Cross-linking was 
37 
 
reversed overnight at 65°C, and DNA isolated using phenol/chloroform/isoamyl alcohol. 
Precipitated DNA was analyzed by quantitative PCR.  
 
Quantitative PCR 
Quantitative PCR was performed with Power SYBR Green PCR Mastermix and the 
PRISM 7500 instrument (Applied Biosystems), and analysis was performed by the 
standard curve method. Primer sequences used for ChIP-PCR analysis can be found in 
Supplemental Table 2. 
 
ChIP-seq 
For each factor, ChIP was performed independently on liver samples from 4 or 5 
different mice, and the precipitated DNA or input DNA samples were pooled. 10ng of the 
pooled DNA were then amplified according to ChIP Sequencing Sample Preparation 
Guide provided by Illumina, using enzymes from New England Biolabs and PCR 
Purification Kit and MinElute Kit from Qiagen. Deep sequencing was performed by the 
Functional Genomics Core (J.Schug and K. Kaestner) of the Penn Diabetes 
Endocrinology Research Center using the Illumina Genome Analyzer IIx, and sequences 
were obtained using the Solexa Analysis Pipeline.  
  
ChIP-seq peak calling and data normalization 
The sequences identified were mapped to the mouse genome (NCBI36/UCSC mm8) 
using BOWTIE software (Langmead et al., 2009).  Only the sequences uniquely mapped 
with no more than 2 mismatches in the first 28 bp were kept and used as valid reads. Peak 
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calling for HDAC3, NCoR and REV-ERB was carried out by MACS (version 1.4.0b, 
allowing multiple reads aligning at the same location; options --mfold 10,30 --pvalue 1e-
5), on each ChIP-seq file against the matching input file (Zhang et al., 2008a). H3K9Ac 
ChIP-seq data was processed by NPS (Zhang et al., 2008b), applying the wavelet 
denoising to define H3K9ac enriched well-positioned nucleosomes.  The signal files 
generated from MACS or NPS (aligned reads encompassing each locus), were 
normalized to the sequencing depth (per million total reads).  Except for the H3K9Ac 
data, PeakSplitter (Salmon-Divon et al., 2010) was further applied to split the nearby 
peaks and find the peak summits by using the normalized signal files, limiting the height 
of peak summit to a minimum of 1. The peak summits were used as the binding site 
centers, and the normalized signal files were used as the binding strength for further 
analysis. 
 
Binding sites annotation and profiling 
CEAS (Cis-regulatory Element Annotation System) (Shin et al., 2009) was applied to 
calculate the enrichment of the binding sites in the promoter, exon, intron, UTR and other 
genomic regions against the mappable mouse genome using the binomial model. CEAS 
was also used to generate the aggregation plot of the normalized binding signals at ± 1 kb 
surrounding site centers at 10 bp resolution. The binding signals of different factors and 
conditions surrounding each site centers are clustered by k-means clustering with the k 
parameter for the number of clusters set to 7. The kmeans function in R is used and the 
centers for each cluster are sorted before the heatmap is drawn. The heatmap color scale 
indicates the binding signals per million total reads for individual factors. The heatmap of 
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Pol II ChIP-seq signals was aligned at transcription start sites considering the orientation 
of genes.  
 
Motif analysis 
To find the enriched DNA motifs at HDAC3 binding site centers, a de novo motif scan by 
MDscan algorithm (Liu et al., 2002) and a search against JASPAR motif collection were 
performed at 600 bps windows around site centers. The motifs were further adjusted 
according to the distance from motif locations to the HDAC3 binding site centers. Details 
of the algorithm are as follows: 
 
Known DNA motifs that are enriched relative to the center of ChIP-seq sites were 
identified using the following statistic. All sites were trimmed or expanded to 600 bp 
centered at the middle point of the identified ChIP-enriched regions. All subsequences 
within the designated window from the site centers were scored by a JASPAR motif or a 
de novo motif from MDscan algorithm to identify hits with a relative entropy cutoff t. Let 
xi, a value between 0 and 1, denote the relative location of motif hit i on the ChIP regions, 
where 0 is the center of the ChIP region and 1 the edge. Out of N total motif hits, we 
define a z-score, 

(xi 0.5) / N /12i1
N
  to assess the positional bias of a motif towards 
the center of the regions. Different integer cutoffs t ≥ 3 were tested for each motif, and 
the cutoff resulting from the highest z was selected. This statistic is based on the 
assumptions that non-significant DNA motifs will be uniformly distributed across the 
ChIP regions and the null distribution of 

x ii1
N
  can be estimated as the N-fold 
convolution of uniform density functions. 
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Gene expression microarray 
Liver samples were taken from the HDAC3
fl/fl 
mice 1 week after injection of AAV-Cre or 
AAV-GFP virus (4 mice per group). Total RNA was extracted from each liver sample 
using the RNeasy Mini Kit (Qiagen). Each RNA sample was processed with the Ambion 
WT Expression Kit and the GeneChip WT Terminal Labeling and Controls Kit 
(Affymetrix), and hybridized to the Mouse Gene 1.0 ST Array (Affymetrix). The array 
was then read by GCS3000 laser scanner (Affymetrix), and microarray data analysis was 
carried out using Partek® Genomics Suite software (Copyright, Partek Inc.).  Data from 8 
samples were subjected to background subtraction, quantile normalization, log2 
transformation and probeset summarization using RMA (Robust Multichip Average) 
algorithm. Only the probe sets that interrogate genes were retained and those meant for 
QC and normalization purposes were excluded from further analysis. Within Partek, a 1-
way ANOVA using genotype as the factor was run on the data to obtain p-values for 
differential expression of genes between the knock-out and WT mice.  The p-values were 
adjusted for step-up p-value or False Discovery Rate (FDR) for each gene. Fold-change 
was multiple testing using the Benjamini-Hochberg step-up method. The gene expression 
microarray and subsequent data analysis were performed by Penn Microarray Core.  All 
mouse RefSeq genes were ranked based on their expression index in the HDAC3
fl/fl
 mice 
injected with AAV-GFP (considered as WT). The top 10%, middle 10% and bottom 10% 
were selected for HDAC3 association study. Genes up-regulated or down-regulated in the 
AAV-Cre injected mouse were selected with a maximum p-value 10
-3 
or a minimum 
absolute fold-change of 1.2. The circadian gene list was obtained from CIRCA website 
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(Hughes et al., 2009), with a maximum COSPOT q-value of 0.001. Based on this list, all 
known genes were divided into circadian genes and non-circadian genes for HDAC3 
association study. The Rev-Erb knockout expression data were downloaded from 
ArrayExpress (E-TABM-726) (Le Martelot et al., 2009).  
 
Association study of HDAC3 and REV-ERB sites 
A gene is bound by HDAC3 or REV-ERB at ZT10, if a predicted binding site is present 
within 10kb from its TSS. Percentages of genes bound by HDAC3 were compared among 
the following gene categories: 1. top 10% expressed, middle 10% and bottom 10% 
expressed genes at ZT10; 2. the up-regulated and down-regulated genes upon loss of 
HDAC3; 3. the circadian and non-circadian genes. The hypergeometric-based test was 
used to calculate the p-value of whether or not HDAC3 or REV-ERB binding is 
significantly enriched in the gene categories comparing to all known mouse genes. The 
distribution function for hypergeometric distribution (phyper from the statistics language 
R) is used as: pvalue = phyper(q,m,n,k,lower.tail=T/F), where m is the number of all the 
genes bound by HDAC3 at the promoter region and n is the number of genes without 
HDAC3 binding, out of k genes in certain category (e.g. circadian genes) q is the number 
of genes bound by HDAC3. The lower.tail is set to F while we calculate the pvalue for 
enrichment or T for depletion. Gene ontology analysis is performed on PANTHER 
website (Thomas et al., 2003).  
 
Analysis of ROR ChIP-seq  
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Sequencing reads were mapped to the mouse genome (UCSC mm8) using Bowtie 
(version 0.12.8). Mapped read must have unique alignment with no more than two 
mismatches in first 27bp. Only uniquely mapped reads were used for peak calling which 
was performed using  FindPeaks algorithm (0.1% FDR) in the HOMER software suite 
(version 3.15., Heinz et al., 2010). Read density plot was produced using HOMER. Read 
density heatmap was generated by seqMiner (Ye et al., 2011). ChIP-seq tracks were 
visualized by Integrated genome viewer (IGV). Motif mining was performed by HOMER 
using 200bp window size. 
 
Oil Red O staining 
5μm frozen sections were prepared from snap-frozen liver tissues, and fixed in 10% 
buffered formalin for 3 minutes. The sections were then stained in 0.5% Oil Red O in 
propylene glycerol overnight for lipid and then in hematoxylin for nucleus for 5 seconds. 
The procedures were performed by the Morphology Core in the Penn Center for 
Molecular Studies in Digestive and Liver Diseases.  
 
Hepatic triglyceride assay 
Liver samples were homogenized in the TissueLyser (Qiagen) with steel beads in tissue 
lysis buffer (140mM NaCl, 50mM Tris and 1% Triton-X, pH8.0). Triglyceride 
concentration in the lysates was then quantified using LiquiColor Triglyceride Procedure 
No. 2100 (Stanbio).  
 
De novo lipogenesis 
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Mice were injected with deuterated water (20 ul/g body weight) intraperitoneally and 
euthanized 3 h post injection. 
2
H-labeled palmitate was extracted from liver and its 
trimethylsilyl derivative was analyzed using gas chromatography-electron impact 
ionization mass spectrometry (GC/MS), and normalized to body water enrichment. The 
percent contribution of newly made palmitate was determined using the equation: % 
newly made palmitate =[total 
2
H-labeled palmitate/ (
2
H-labeled body water ×n)] ×100 
where n is the number of exchangeable hydrogens, assumed to equal 22. The absolute 
amount of newly synthesized palmitate was determined by multiplying the % newly 
made palmitate by the concentration of palmitate (Leavens et al., 2009).  
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Table 2.1 List of Primers for Gene Expression 
Gene Forward Primer Reverse Primer 
Arbp TCATCCAGCAGGTGTTTGACA GGCACCGAGGCAACAGTT 
Bmal1 TAGGATGTGACCGAGGGAAG TCAAACAAGCTCTGGCCAAT 
Npas2 CAGCTTGAACCCAAAGGAAT CCATTACAGGAGGGGCTAGG 
ROR TGTTTGATTGATCGGACCAG CTTGGACATCCGACCAAACT 
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Table 2.2 List of Primers for ChIP-PCR 
Gene Forward Primer Reverse Primer 
Arbp GAGGTGGCTTTGAACCAGAG TCTTTGTCTCTGTCTCGGAAAA 
Ins GGACCCACAAGTGGAACAAC GTGCAGCACTGATCCACAAT 
Bmal1 AGCGGATTGGTCGGAAAGT ACCTCCGTCCCTGACCTACT 
Npas2 TTGCAGAAGCTTGGGAAAAG TTTCCTGTGGGAGGAGACAG 
HDAC3 binding sites 
1 AGACCTGGCAGTTGCATTTT TGGACGGACAGTCGAGTAGA 
2 CCTTGGCTGCATACTGAGGT  AGAGCCAGGTGAGATCCTGA 
3 GGGAGGAAATGGAGAAGAGG CAAATGGAGTTCCCAGCAAT 
4 TGGCCAGATGCTCAGAGTTC ACAGAAGCATGAGGCCAACT 
5 AACTCTCAGCCTCCAGAGCA GGACAGGTCACCAGGGTATG 
6 GAGTGTGCGCCAGAGATACA CCTTGGCTGAGGGACTGTAA 
ROR binding sites 
1 TCCTTATGCCACTTCCAAAA ATGCTAAACCACCCACTGGT 
2 GCTGACGTCTACAATTGGGTTA CAATTGACTCCTTTGGCTCTG 
3 TGATGACAGCTTTCCCAACA GCCCATGTGACATTCCCTAT 
4 AGCCAAAACAGGTTGCCTAA GGTGAAGGTCAGCTGGAAAA 
5 CCAAGGTCATGTTCATGCTG TGGGTCAGTCACTTTGGTCA 
6 GTCTGTAATGGGGCCATCG GGCTGCCAAAACCACTATGT 
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3.1 Abstract 
Disruption of the circadian clock exacerbates metabolic diseases including obesity and 
diabetes.  Here we show that histone deacetylase 3 (HDAC3) recruitment to the genome 
displays a circadian rhythm in mouse liver.  Histone acetylation is inversely related to 
HDAC3 binding, and this rhythm is lost when HDAC3 is absent.  Although amounts of 
HDAC3 levels are constant, its genomic recruitment in liver corresponds to the 
expression pattern of the circadian nuclear receptor REV-ERB.  REV-ERB colocalizes 
with HDAC3 near genes regulating lipid metabolism, and deletion of HDAC3 or REV-
ERB in mouse liver causes hepatic steatosis.  Thus, genomic recruitment of HDAC3 by 
REV-ERB directs a circadian rhythm of histone acetylation and gene expression 
required for normal hepatic lipid homeostasis. 
 
3.2 Introduction 
3.2a Circadian Metabolism and Histone Acetylation  
In mammals, metabolic processes in peripheral organs display robust circadian rhythms, 
coordinated with the daily cycles of light and nutrient availability (reviewed Green et al., 
2008; Ramsey and Bass, 2011). Maintaining the circadian rhythms in metabolism is 
critical for metabolic homeostasis. Circadian misalignment causes metabolic dysfunction, 
and people engaged in night-shift work suffer from higher incidences of obesity, diabetes, 
and metabolic syndrome (De Bacquer et al., 2009; Pietroiusti et al., 2010; Scheer et al., 
2009).  The molecular basis of this is unknown, but genetic disruption of circadian clock 
components in mice leads to altered glucose and lipid metabolism (Lamia et al., 2008; 
Marcheva et al., 2010; Rudic et al., 2004; Turek et al., 2005).   
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Gene expression profiles in multiple metabolic organs have revealed a circadian control 
of the transcriptome, which might be mediated by regulation of histone acetylation that 
alters the structure of the epigenome (Akhtar et al., 2002; Balsalobre et al., 1998; 
McCarthy et al., 2007; Panda et al., 2002; Storch et al., 2002; Ueda et al., 2002; Zvonic et 
al., 2006). Histone acetylation undergoes cyclic oscillation with the clock, as evident in 
mouse liver, not only at the promoters of the clock genes and but also in a genome-wide 
scale (Curtis et al., 2004; Etchegaray et al., 2003; Naruse et al., 2004; Ripperger and 
Schibler, 2006). Histone acetylation is complex, involving multiple histone 
acetyltransferase (HATs) and histone deacetylases (HDACs) (Strahl and Allis, 2000).  .  
 
3.2b Histone Acetylation and Histone Deacetylase  
In eukaryotes, genomic DNA is packaged with histone proteins. There are four core 
histone proteins: H2A, H2B, H3 and H4. Histones form an octamer with two copies of 
each core histone, and each octamer is wrapped by genomic DNA of approximately 
146bp, forming the basic unit of chromatin, known as the nucleosome. All histone 
proteins have a 15-30 amino acid unstructured N-terminal, known as the histone tails. 
The tails contains multiple lysine residues, which are subject to covalent modification, 
such as acetylation, methylation and ubiquitination. Here we only discuss histone 
acetylation.  
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Numerous evidences demonstrate that histone hyperacetylation is highly correlated with 
transcription activation, and suggest that histone acetylation can promote transcription. 
However, the cause-and-effect relationship has not been confirmed (Kimura et al., 2005). 
Multiple lysines in the histone octamer can be acetylated in vivo, including histone H3 
lysine 4 (H3K4), H3K9, H3K14, H3K18, H3K23, H3K27, H4K5, H4K8, H4K12 and 
H4K16. It was originally believed that histone acetylation activates transcription through 
neutralizing positive charges and reducing the electrostatic interaction between histones 
and the negatively charged DNA. Such a model was strongly challenged by the findings 
that acetylation on different lysines has specific effects and that HATs and HDACs have 
residue specificity (reviewed in Kimura et al., 2005; Strahl and Allis, 2000).  
 
Histone deacetylases (HDACs) can be divided into four different classes: Class I 
(HDAC1/2/3/8), Class II (HDAC4/5/6/7/9/10), Class III (sirtulins), and Class IV 
(HDAC11) (reviewed in Witt et al., 2009). Class I HDACs are usually members of the 
multi-protein corepressor complexes, and are critical for transcriptional regulation and 
histone modification. For instance, HDAC1 and HDAC2 are in the NuRD complex, 
while HDAC3 is in the NCoR and SMRT complexes. Here we only focus on HDAC3, 
which is known to function in the regulation of circadian rhythm and glucose metabolism 
(Alenghat et al., 2008).   
 
HDAC3 is ubiquitously expressed, and plays an crucial role in development and 
metabolic homeostasis. Germline deletion of HDAC3 causes embryonic lethality before 
day 9.5. In mouse embryonic fibroblasts (MEFs), loss of HDAC3 also leads to a delay in 
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cell cycle progression, cell cycle dependent DNA damage and apoptosis (Bhaskara et al., 
2008). Liver-specific knockout of HDAC3 causes hepatic steatosis (Knutson et al., 2008). 
 
3.3 Results 
3.3a Circadian Binding of HDAC3 at ZT10 and ZT22 in Liver 
We hypothesized that HDAC3 displays different genomic binding and transcriptional 
activity at different times of the day. To test this hypothesis, we kept wildtype C57Bl/6 
mice under 12h-light/12h-dark cycles for at least two weeks in an isolated chamber 
without disturbance (Figure 3.1). We profiled HDAC3 bindings at two time points: 
5pm/ZT10 and 5am/ZT22 using chromatin immunoprecipitation followed by massively 
parallel DNA sequencing (ChIP-seq), and discovered diurnal recruitment of HDAC3 to 
the mouse liver genome. At ZT10, in the light period when mice are inactive, HDAC3 
bound over 14,000 sites in adult mouse liver (the HDAC3 ZT10 cistrome). At ZT22, in 
the dark period when mice are active and feeding, only 120 specific peaks remained 
(Figure 3.2A).  The binding signals at the binding sites decreased significantly from 
ZT10 to ZT22 (Figure 3.2B, C), which was also validated with ChIP-PCR using a 
different antibody (Figure 3.3A). HDAC3 binding was absent when HDAC3 was deleted 
in liver, suggesting that the antibody used for ChIP-seq is highly specific to HDAC3 
(Figure 3.3B). Further analysis of the HDAC3 ZT10 cistrome revealed that a majority of 
these binding sites were distant from transcription start sites (TSSs) or present in introns 
(Figure 3.4).  
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HDAC3 recruitment oscillates in a 24-hour cycle (Figure 3.5). Such a rhythm was 
retained in constant darkness (Figure 3.6A), suggesting that it was controlled by the 
circadian clock.  The liver clock is entrained by food intake (Damiola et al., 2000) and, 
indeed the pattern of HDAC3 enrichment was reversed when food was provided only 
during the light period (Figure 3.6B), further supporting the conclusion that the rhythm of 
HDAC3 genomic recruitment was controlled by the liver clock.  
 
3.3b Histone Acetylation Is Inversely Correlated with HDAC3 Binding 
Despite its known role in histone deacetylation and transcriptional repression, HDAC3 
recruitment has been reported to be associated with high histone acetylation, RNA 
polymerase II (Pol II) recruitment, and gene expression in human primary T cells (Wang 
et al., 2009).  In mouse liver, HDAC3 recruitment at ZT10 was also enriched around 
active genes (Figure 3.7A), and many of these display circadian expression patterns 
(Hughes et al., 2009)( Figure 3.7B). Thus HDAC3 may have an important role in 
transient regulation of these active genes by the circadian clock.  
 
Consistent with this hypothesis, we observed decreases in acetylation of histone H3 
lysine 9 (H3K9) at ZT10 compared with that at ZT22, the inverse of HDAC3 recruitment 
to these sites (Figure 3.8A,B).  We then deleted HDAC3 in mouse liver by tail vein 
injection of adeno-associated virus expressing cre-recombinase (AAV-Cre) into adult 
C57Bl/6 mice homozygous for a floxed HDAC3 allele (HDAC
fl/fl
)(Figure 3.3B). Loss of 
HDAC3  led to H3K9 acetylation at ZT10 comparable that of wild type (WT) mice at 
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ZT22 (Figure 3.8).  Our results suggest that circadian binding of HDAC3 drives rhythmic 
histone acetylation in the mouse liver genome.  
 
In consistent with its role in histone deacetylation and transcription repression, HDAC3 
binding is associated with transcription repression. The majority of genes whose 
transcripts were increased 1 week after HDAC3 deletion in liver displayed HDAC3 
binding within 10 kb of their TSSs in WT mice at ZT10 (Figure 3.7C).  Thus, genome-
wide diurnal recruitment of HDAC3 directs a rhythm of epigenomic modification and 
gene expression.  
 
3.3c REV-ERB Mediates HDAC3 Recruitment 
Although HDAC3 recruitment to the genome was diurnal, the abundance of HDAC3 was 
constant throughout the light/dark cycle (Figure 3.10A). In addition, HDAC3 does not 
bind genome directly, and is usually present in the NCoR/SMRT corepressor complex, 
which mediates transcription repression by nuclear receptors (Guenther et al., 2000; 
Ishizuka and Lazar, 2003; reviewed in Hu and Lazar, 2000).  Moreover, HDAC3 enzyme 
activity requires interaction with nuclear receptor (NR) corepressors (Guenther et al., 
2001). Therefore, we hypothesized that HDAC3 is recruited by nuclear receptors in a 
circadian manner. In consistent with our hypothesis, De novo motif analysis of the 
HDAC3 binding sites revealed the classical motif recognized by a number of NRs 
(Figure 3.9).   
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The NR REV-ERB is a transcriptional repressor that is expressed in a circadian manner, 
and the abundance of REV-ERB protein oscillated in phase with HDAC3 recruitment 
(Preitner et al., 2002) (Figure 3.10A).  REV-ERB is also known to recruit the NCoR 
corepressor complex and HDAC3 to repress transcription of Bmal1 (Yin and Lazar, 
2005). To test the hypothesis that REV-ERB recruits HDAC3 in a circadian manner, we 
used ChIP-seq to identify the REV-ERB binding sites. At ZT10, the REV-ERB 
binding sites overlapped with the majority of HDAC3 binding sites (Figure 3.10B).  The 
binding signals decreased significantly in the Rev-erb knockout liver, suggesting that 
the signals are specific to REV-ERBFigure 3.10C). Similar to HDAC3, a majority of 
the REV-ERB binding sites were distant from TSSs or in the introns (Figure 3.11A,B). 
In consistent with the hypothesis that REV-ERB recruits HDAC3 to repress its target 
genes, most of the genes upregulated in liver depleted of REV-ERB (Kornmann et al., 
2007) were bound by HDAC3 as well as REV-ERB at ZT10 (Figure 3.11C).  
 
Furthermore, REV-ERB bound the majority of HDAC3 ZT10 sites at ZT10 but not 
ZT22 (Figure 3.12B).  The extent of overlapping between HDAC3 binding and REV-
ERB binding was surprising given that other NRs can interact with corepressors and 
HDAC3 (Goodson et al., 2005). However, HDAC3 recruitment was indeed diminished at 
many sites in Rev-erb knockout mice (Figure 3.13A), consistent with a critical role for 
REV-ERB in HDAC3 recruitment.  The residual HDAC3 binding at other sites suggests 
that other factors also contribute to its recruitment. A likely candidate is REV-ERB, 
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whose DNA binding domain is 95% homologous to the REV-ERB(Renaud et al., 2000; 
Retnakaran et al., 1994).  
 
REV-ERB recruits HDAC3 via the nuclear receptor corepressor (NCoR) (Yin and 
Lazar, 2005; Zamir et al., 1997). The NCoR ZT10 cistrome largely overlapped with the 
REV-ERB cistrome and the HDAC3 cistrome (Figure 3.12A). NCoR was recruited to 
HDAC3 sites with a similar diurnal rhythm (Figure 3.12B). Like HDAC3, NCoR binding 
at many REV-ERB binding sites was also attenuated in Rev-erb knockout mice 
(Figure 3.13B). In conclusion, our findings support the hypothesis that HDAC3 is 
recruited by REV-ERB through NCoR in a circadian manner.  
 
3.4c HDAC3 Regulates Hepatic Lipid Biosynthesis 
In order to understand the biological role of the circadian genomic recruitment of 
HDAC3 in mouse liver, we performed gene ontology study on genes bound by REV-
ERB and HDAC3, and upregulated in livers depleted of HDAC3. We defined genes 
bound by REV-ERB as genes that have at least one REV-ERB binding site within 
10kb from the TSSs. This set of genes are most likely the direct targets of HDAC3, and 
were enriched in genes involved in lipid metabolic processes (Figure 3.14). Therefore, we 
hypothesized that circadian binding of HDAC3 plays an important role in regulating lipid 
homeostasis. Indeed, in chow fed mice in which hepatic HDAC3 was deleted for 2 weeks, 
we observed dramatic increase in neutral lipid by Oil Red O staining (Figure 3.15A). In 
consistent with this observation, liver triglyceride content was increased by nearly 10 
55 
 
folds (Figure 3.16B). This was consistent with a fatty liver phenotype of mice depleted of 
hepatic HDAC3 in utero [(Knutson et al., 2008)and Figure 3.15C].   
 
REV-ERB mediates the circadian recruitment of HDAC3. Therefore we hypothesized 
that loss of Rev-erb in liver also causes steatosis. Indeed, in chow-fed 9 week old 
C57Bl/6 mice genetically lacking Rev-erbOil Red O staining of liver was also 
increased (Figure 3.16A), and hepatic triglyceride content was nearly double that of WT 
mice (Figure 3.16B). Both the HDAC3 liver-specific knockout mice and the Rev-erb 
knockout mice show normal serum transaminase activity, indicating little or no liver 
damage (data not shown). The relatively modest hepatic steatosis in the Rev-erb 
deficient mice likely reflects a role for HDAC3 in mediating effects of other NRs, 
including REV-ERB whose circadian expression pattern is similar to that of REV-
ERB (Liu et al., 2008a), but could also reflect a compensatory effect of REV-ERB 
depletion in other tissues.  Nevertheless the finding that depletion of either REV-ERB 
or HDAC3 led to a fatty liver phenotype supports the conclusion that circadian REV-
ERB recruitment of HDAC3 to lipid metabolic genes plays a critical physiological role.   
 
In consistent with increase in lipid content, de novo lipogenesis in mice lacking hepatic 
HDAC3 (Figure 3.17A) or in Rev-erb knockout mice (Figure 3.17B) was significantly 
elevated. De novo lipogenesis rate was assessed through hepatic palmitate synthesis after 
injection of deuterated water. This supports that HDAC3 and REV-suppress 
hepatic lipid biosynthesis, and provides a molecular mechanism underlying the 
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observation that hepatic lipogenesis in mice follows a diurnal rhythm (Hems et al., 1975) 
that is anti-phase to REV-ERB and HDAC3 recruitment to the mouse genome.  
 
3.4 Discussion and Future Directions 
Our findings demonstrate the existence of circadian changes in histone acetylation whose 
dysregulation has the potential to cause major perturbations in normal metabolic function.  
Each day, low concentrations of REV-ERB lead to reduced HDAC3 association with 
the liver genome while the organism is active and feeding, altering the epigenome to 
permit lipid synthesis and accumulation until abundance of REV-ERB increases 
HDAC3 recruitment to liver metabolic genes halts the lipid build-up (Figure 3.18).  
When either Rev-erb or HDAC3 is depleted, this cycle does not occur and fatty liver 
ensues.   
 
Misalignment of fasting/feeding and sleep/wake cycles with endogenous circadian cycles 
could disrupt the rhythm of HDAC3 association with target genes and contribute to the 
fatty liver observed in rotating shift workers as well as people with genetic variants of 
molecular clock genes (Brunt, 2010; Sookoian et al., 2007).   
 
Although our results suggest that HDAC3 is recruited to the mouse liver genome in a 
circadian manner, and that HDAC3 recruitment at many sites is dependent on REV-
ERB, we cannot rule out that other nuclear receptors also play a role in the diurnal 
recruitment of HDAC3. Participation of other nuclear receptors is supported by the 
observation that mice without HDAC3 exhibited a much more severe fatty liver 
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phenotype than mice without Rev-erb. Many other nuclear receptors are expressed in a 
similar rhythm as REV-ERB, and can mediate diurnal HDAC3 recruitment. Among 
them is nuclear receptor REV-ERB, which has an almost identical DNA binding 
domain as REV-ERB. The Rev-erb transcript oscillates almost exactly in phase with 
the Rev-erb transcript in liver. In vitro studies showed that REV-ERB recognizes the 
same motif and regulates some known REV-ERB target genes. Another candidate 
nuclear receptor is PPAR, which shares the same expression rhythm as REV-ERBs in 
liver (Yang et al., 2006). Motif analysis of the HDAC3 ZT10 cistrome also revealed a 
DR1 nuclear receptor motif known to be bound by PPAR/RXR heterodimer (data not 
shown). In addition, Glucocorticoid Receptor has been shown to interact with NCoR. GR 
recognizes a distinct motif and is stably expressed in liver (Yang et al., 2006). However, 
its genomic binding is regulated by ligands such as corticosterone, and the plasma 
corticosterone level is controlled by the circadian clock and is higher at ZT10 (Oster et al., 
2006). Moreover, glucocorticoid has been shown to drive daily oscillation of metabolic 
genes in liver (Reddy et al., 2007).  
 
Another question is whether HDAC3 activity is controlled solely by the circadian clock 
and REV-ERBs. The answer may be ‘No’. First, previous work in our lab showed that 
REV-ERB is subject to post-translational regulation by GSK3 and ubiquitin E3 ligase 
ARF-BP/PAM (Yin et al., 2010). This raised the possibility that REV-ERB can be 
regulated by environmental cues and adjusts the genomic binding of HDAC3. Secondly, 
HDAC3 recruitment by REV-ERB is regulated by heme binding, and heme may serve 
as sensor for the intracellular metabolic state (Yin et al., 2007). Furthermore, If HDAC3 
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binding is regulated by other nuclear receptors, such as PPAR and GR, it is likely to 
respond to fasting/feeding and hormone secretion at the PPAR and GR binding sites. It 
may be interesting to separate the HDAC3 bindings that are regulated by the circadian 
clock from those regulated by metabolic signals.  
 
In vitro studies showed that REV-ERB regulates target gene expression through both 
active and passive repression. In active repression involving NCoR and HDAC3, REV-
ERB binds either a DR2 element as a homodimer or two monomer sites spaced apart. In 
passive repression, REV-ERB binds the monomer sites and competes with transcription 
activator RORs. Here we reported that REV-ERB actively represses clock and 
metabolic genes by recruiting HDAC3 in liver, but motif analysis did not reveal 
enrichment of the DR2 element, but instead the monomer motif shared by RORs. The 
lack of DR2 element suggest that in most cases, REV-ERB binds to two monomer sites 
spaced apart and collaboratively recruit NCoR and HDAC3 as shown in the Bmal1 
promoter (Yin and Lazar, 2005).  Indeed, a motif scan performed later showed that 
approximately 35% of all the REV-ERB binding sites contain at least two half sites  and 
that many REV-ERB binding sites are located in close proximity to another (less than 
2kb) (Bugge et al., 2012). The monomer/ROR motif by the motif analysis suggests that 
REV-ERB may repress transcription by directly competing with RORs. And we will 
explore passive repression in the next chapter.  
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Figure 3.1 Zeitgeber Time. Mice were housed under the regular 12h light/ 12h dark 
cycles. Light is on at ZT0 (7am), and off at ZT12 (7pm). ZT10 corresponds to 5pm, and 
ZT22 corresponds to 5am.  
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Figure 3.2 Diurnal Binding of HDAC3 in Mouse Liver.  
A. Overlapping of HDAC3 cistromes at ZT10 (Blue) and ZT22 (Red).  A pair of ZT10 
and ZT22 binding sites was considered overlapping when their centers were within 200bp 
of each other.  
B.  Heatmap of HDAC3 binding signal at ZT10 (left) and ZT22 (right) from -1kb to +1kb 
surrounding the center of all the HDAC3 ZT10 binding sites, ordered by strength of 
HDAC3 binding. Each line represents a single HDAC3 binding site and the color scale 
indicates the HDAC3 signal (reads encompassing each locus per million total reads).  
A B 
C 
C 
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C. Average HDAC3 signal from -1kb to +1kb surrounding the center of all the HDAC3 
ZT10 binding sites. The Y axis represents the HDAC3 signal per million total reads. ZT, 
Zeitgeber time.  
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Figure 3.3 Validation of HDAC3 Binding Sites.  
A. Diurnal recruitment of HDAC3 as shown by ChIP-PCR with a different HDAC3 
antibody (sc-11417). Six HDAC3 binding sites were interrogated by ChIP-PCR. The 
Bmal1 gene promoter was used as a positive control, and regions close to the TSSs of the 
Arbp and Ins genes served as negative controls. Values are mean ± s.e.m. (n=4-5).  
B. HDAC3 enrichment at HDAC3 binding sites interrogated by ChIP-PCR is largely 
diminished upon loss of HDAC3.  
C. Depletion of HDAC3 in liver from HDAC3
fl/fl
 mice 1 week after injection of the 
AAV-Cre virus. AAV-GFP virus was used as a negative control and protein levels of 
HDAC3 and Ran (loading control) were measured by western blot.  
  
A 
B C 
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Figure 3.4 Genomic Distribution of HDAC3 ZT10 Cistrome.  
A. Distribution of the HDAC3 ZT10 binding sites relative to known genes.   
B. Percentage of the HDAC3 ZT10 sites (green) located at different positions relative to 
known genes in comparison with the mappable mouse genome (blue). The percentage 
was calculated by CEAS as described in Methods, and the p-values indicate the 
significance of the differences between the HDAC3 ZT10 cistrome and the mappable 
mouse genome.   
B 
A 
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Figure 3.5 HDAC3 Binding Oscillates in a 24h Cycle. HDAC3 recruitment at 2 
selected genomic sites over a 24h cycle by ChIP-PCR.  Immunoprecipitated DNA was 
normalized to input. Values are mean ± s.e.m. (n=4-5). 
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Figure 3.6 Diurnal Binding of HDAC3 Is Controlled by the Liver Clock.  
A. Diurnal HDAC3 genomic recruitment is maintained in constant darkness.  Six 
HDAC3 binding sites were assessed by ChIP-PCR (n=4-5). The Bmal1 promoter (Bmal1) 
served as a positive control, and regions close to the TSS of the Arbp and Ins genes 
served as negative controls.   
B. The rhythm of HDAC3 recruitment is reversed by day-time feeding (n=4-5).  RF, food 
was provided only from ZT3 to ZT11 every day for 2 weeks.  
 
  
A 
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Figure 3.7 HDAC3 Functions as a Transcription Repressor near Active and 
Circadian Genes.  
A. HDAC3 binds mainly to active genes. All mouse RefSeq genes were ranked based on 
their expression index in ZT10 mouse liver, and genes among the top 10%, middle 10% 
and bottom 10% were selected. *p-value~10
-279
 
B. HDAC3 binds mainly to circadian genes. All known genes were divided into circadian 
genes and non-circadian genes. The percentage of HDAC3 bound genes in each category 
was calculated, and compared with all genes. *p-value~10
-136
. 
C. Genes up-regulated in liver depleted of HDAC3 are significantly enriched for HDAC3 
binding at ZT10. Expression arrays of WT and HDAC3 KO liver were performed and 
analyzed as described in Methods, and the percentage of HDAC3 bound genes in each 
C 
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category was calculated. *p~10
-156
. p-values were calculated based on hypergeometic 
distribution.  
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Figure 3.8 Histone Acetylation Is Inversely Correlated with HDAC3 Binding.  
A. Heatmap of the histone H3 lysine 9 acetylation (H3K9Ac) signal at ZT22 (left), ZT10 
(middle) and ZT10 in liver depleted of HDAC3 (KO) (right) from -1kb to +1kb 
surrounding the center of all the HDAC3 ZT10 binding sites. Each line represents a 
single HDAC3 binding site and the color scale indicates the H3K9Ac signal per million 
total reads. HDAC3 depleted liver was removed from HDAC3
fl/fl
 mice 1 week after 
injection of AAV-Cre.   
B. Average H3K9Ac signal from -1kb to +1kb surrounding the center of all the HDAC3 
ZT10 binding sites. The Y axis represents the HDAC3 signal per million total reads. 
A B 
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Figure 3.9 Motif Analysis of the HDAC3 ZT10 Cistrome Reveals a Canonical 
Nuclear Receptor Half Site. Sequences within ± 300bp from the centers of all the 
HDAC3 sites were used for de novo motif analysis (Top) and motif scan against the 
JASPAR database (Bottom), and the most enriched motif for each analysis is shown.  
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Figure 3.10 REV-ERBa Cistrome Overlaps with HDAC3 Cistrome at ZT10.  
A. Immunoblot of HDAC3 and REV-ERB over a 24h cycle in mouse liver.  HSP90 
protein levels are shown as loading control.  
B. The HDAC3 ZT10cistrome largely overlaps with the REV-ERB ZT10 cistrome.  
HDAC3 binding sites and REV-ERB binding sites were considered overlapping when 
their centers were within 200bp of each other. 
C. REV-ERB enrichment interrogated by ChIP-PCR is largely diminished in Rev-erb 
KO liver at ZT10, demonstrating that the REV-ERB antibody is specific.   
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Figure 3.11 Genomic Distribution of the REV-ERB ZT10 Cistrome.  
A. Distribution of REV-ERB ZT10 sites relative to known genes.  
B. Percentage of the REV-ERB ZT10 sites (green) located at different genomic regions 
relative to known genes compared with the mappable mouse genome (blue). The 
percentage of all sites in each group was calculated by CEAS. 
C. Genes up-regulated in Rev-erb KO liver are enriched for both HDAC3 and REV-
ERB binding at ZT10 in mouse liver. Genes up-regulated at ZT12 in the liver of the 
Rev-erb KO mouse were identified using published expression array data (Le Martelot 
et al., 2009). Among these, the percentage of genes bound by both HDAC3 and REV-
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ERB were calculated, and compared with all genes. p-values above each column 
indicates the significance of difference and were calculated based on hypergeometric 
distribution. 
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Figure 3.12 REV-ERBRecruits NCoR Corepressor and HDAC3 with a Circadian 
Rhythm.  
A. HDAC3 (green) ZT10 cistrome largely overlapped with both REV-ERB (red) and 
NCoR cistrome at ZT10 (blue). Binding sites were considered overlapping when their 
centers were within 200bp of each other. Numbers indicates the percentage of all HDAC3 
binding sites in each group.  
B. Heatmap of REV-ERB binding at ZT10 and ZT22 (left) and of NCoR at ZT10 and 
ZT22 (right), both at HDAC3 ZT10 sites ordered as in Figure 3.2. Each line represents a 
single HDAC3/REV-ERB binding site and the color scale indicates the signal per 
million total reads. 
A 
 
B 
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Figure 3.13 Loss of HDAC3 and NCoR Recruitment upon Rev-erb Deletion. 
A. HDAC3 recruitment to six binding sites in liver from mice lacking Rev-erb was 
interrogated by ChIP-PCR. 
B. NCoR recruitment to six binding sites in liver from mice lacking Rev-erb was 
interrogated by ChIP-PCR. The Bmal1 gene promoter (Bmal1) was used as a positive 
control, and regions close to the TSS of the Arbp and Ins genes served as negative 
controls.  Values are mean ± s.e.m. (n=3). 
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Figure 3.14 HDAC3 and REV-ERB Regulate Lipid Metabolic Genes Gene 
ontology analysis of the HDAC3 and REV-ERB-bound genes that were up-regulated in 
liver depleted of HDAC3 was performed using Panther (Thomas et al., 2003).   
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Figure 3.15 Loss of HDAC3 Causes Liver Steatosis.  
A. Oil Red O staining of liver from 14 week old HDAC3
fl/fl
 mice 2 weeks after tail vein 
injection of AAV-GFP or AAV-Cre.  
B. Hepatic triglyceride (TG) levels in mice treated as in “A”. Values are mean ± s.e.m. 
(n=4). *p<0.05 by student’s t-test. 
C. Enlarged and fatty liver in 8 week old male HDAC3
fl/fl
/Alb-Cre mice. Livers from 
HDAC3
fl/fl
 mice and HDAC3
fl/+
/Alb-Cre mice are used as negative controls. Alb-Cre, the 
cre recombinase gene under a liver-specific Albumin promoter.  
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Figure 3.16 Loss of Rev-erb Causes Hepatic Steatosis.  
A. Oil Red O staining of liver from 9 week old WT and mice lacking Rev-erb (Rev-
erb KO).  
B. Hepatic TG levels in from livers from 9 week old WT and mice lacking Rev-erb 
(Rev-erb KO). Values are mean ± s.e.m. (n=4). *p<0.05 by student’s t-test. 
 
 
 
  
A 
B 
78 
 
 
Figure 3.17 Hepatic Lipogenesis Is Upregulated in the Absence of HDAC3 or REV-
ERB.  
A. Hepatic de novo lipogenesis (DNL) in 13 week old HDAC3
fl/fl
 mice 1 week after 
infection with AAV-Cre or with AAV-GFP. Values are mean ± s.e.m. (n=7-8). 
B. Hepatic de novo lipogenesis (DNL) in 14 week old Rev-erb KO mice or WT mice. 
Hepatic DNL was measured as newly synthesized and 
2
H labeled palmitate as in Methods.  
Values are mean ± s.e.m. (n=7-8).  *p<0.05 by student’s t-test.  
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Figure 3.18 Model of REV-ERB and HDAC3 Function in Liver. In the day time, 
when mice are inactive and fasting, REV-ERB recruits NCoR/HDAC3, which 
deacetylates histone and represses lipid biosynthetic genes. At night, when mice are 
active and feeding, REV-ERB is absent, and the dissociation of NCoR/HDAC3 from 
the genome allows histone acetylation and transcriptional activation of lipid biosynthetic 
genes. Through this mechanism, REV-ERB and HDAC3 contribute to the circadian 
oscillation of lipogenesis in liver.  
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Table 3.1 List of ChIP-seq Data 
 total reads Non-redundant 
# of peaks 
(SPMR>=1) 
Rev-Erb 5pm (2 reps) 30,637,929 19,995,375 30,787 
Rev-Erb 5am 12,782,094 11,451,185 984 
HDAC3 5pm (3 reps) 42,315,338 28,873,243 14,578 
HDAC3 5am (2 reps) 34,786,996 33,139,525 120 
NCoR 5pm 18,875,895 18,236,535 23,817 
NCoR 5am 16,833,313 16,286,483 5,258 
H3K9Ac 5pm 12,022,705 NA 122,331 (NPS) 
H3K9Ac 5pm after HDAC3 
KO 
19,904,250 NA 257,421 (NPS) 
H3K9Ac 5am 22,073,824 NA 224,639 (NPS) 
5pm Input 20,346,220 16,564,474 NA 
5am Input 24,056,755 15,555,656 NA 
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Chapter 4  
Circadian Regulation of Hepatic Metabolism  
by REV-ERB and ROR 
 
 
 
 
 
Published in part in Genes & Development, 2012, 25(23):2480-8 
 
The text, figures, and legends in this chapter were the work of Dan Feng with the 
following exceptions. Experiments on REV-ERB from Figure 4.2 to 4.5 were jointly 
conducted by Dan Feng and Anne Bugge, and the figures were plotted by Anne Bugge 
except for Figure 4.3B. Experiments from the Genes & Development manuscript that 
were conducted solely by Anne Bugge were not included. Bin Fang conducted the 
bioinformatics analysis on ROR ChIP-seq. David Steger provided GR ChIP-seq data in 
liver. Zheng Sun provided livers from the HDAC3
fl/fl
 mice. Lindsey Peed provided 
technical assistance.  
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4.1 Abstract 
The nuclear receptor REV-ERB regulates circadian rhythm and metabolism. In 
particular, REV-ERB, through HDAC3, directs a circadian rhythm of histone 
acetylation and gene expression that is crucial for metabolic homeostasis. But Rev-erb 
deletion has modest effects on both circadian rhythms and metabolism, and it has been 
considered to be a secondary regulator of the cell-autonomous clock. Here we report that 
a highly related nuclear receptor REV-ERB binds genome with a circadian rhythm 
similar to that of REV-ERB. Depletion of REV-ERB in Rev-erb knockout liver 
further decreases HDAC3 recruitment, de-represses clock genes, and exacerbates hepatic 
steatosis. Loss of both REV-ERBs completely abolishes the circadian rhythm, as shown 
in mouse embryonic fibroblasts. These findings establish the two REV-ERBs as major 
regulators of both clock function and metabolism. In addition to HDAC3, REV-ERBs can 
passively repress gene expression by competing with RORs. We report that ROR binds 
Bmal1 and Npas2 genes with a diurnal rhythm anti-phase to that of REV-ERBs. REV-
ERBs represses ROR binding at ZT10 and thus drives the diurnal recruitment of ROR, 
which is expressed at a constant levelRepression by REV-ERBs is independent of 
HDAC3, suggesting that REV-ERBs represses ROR binding through direct competition. 
We identify thousands of competing sites similar to those in Bmal1 and Npas2 genes by 
ROR ChIP-seq at ZT10 and ZT22, many of which are in close proximity of clock and 
metabolic genes. Functions of ROR in liver will be tested in mouse models of liver-
specific deletion of ROR and its paralog ROR. We also discover thousands of ROR 
binding sites with little or no difference in ROR binding between ZT10 and ZT22, and 
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sites where ROR binds in phase with REV-ERBs. How ROR recruitment is regulated 
at these non-competing or in-phase sites remains to be elucidated.  
 
4.2 Introduction 
4.2a REV-ERB 
In Chapter 3, we show a circadian rhythm of REV-ERB binding at thousands of 
genomic sites, which is consistent with the dramatic oscillation of REV-ERB protein. 
We also show that REV-ERB recruits the NCoR corepressor complex and HDAC3, and 
drives the circadian oscillation of histone acetylation and gene expression. We discovered 
that REV-ERB and HDAC3 binding are enriched near lipid metabolic genes, and that 
loss of Rev-erb or HDAC3 leads to hepatic steatosis. However, loss of Rev-erb has 
minor effects in comparison with loss of HDAC3, raising the question whether other 
nuclear receptors also play a role in recruiting HDAC3 and suppressing hepatic lipid 
biosynthesis.  
 
Loss of Rev-erb also has a modest effect on circadian rhythm (Preitner et al., 2002). 
Although the circadian expression of Bmal1 and Clock is severely blunted in the liver of 
the Rev-erb-deficient mice, the circadian expression of Cry2 and Per2 are almost intact. 
When these mice were put into constant darkness, they maintained circadian locomoter 
activity, suggesting that the circadian rhythm was not disrupted, though the circadian 
period is slightly yet significantly shorter in these mice (Preitner et al., 2002). These 
findings argue that REV-ERB only plays an auxiliary role in the circadian clock. 
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However, the basic clock machinery is featured by the redundancy of its components 
(DeBruyne et al., 2007; van der Horst et al., 1999; Shi et al., 2010; Zheng et al., 2001). 
Therefore, we hypothesized that a closely related nuclear receptor REV-ERB can 
compensate for loss of REV-ERB, and the REV-ERBs are essential components of the 
core clock.  
 
Like REV-ERB, REV-ERB is also considered an orphan nuclear receptor (Retnakaran 
et al., 1994). It is the most closely related nuclear receptor to REV-ERB (>95% 
identical in the DNA binding domain, and >65% identical in the ligand binding domain). 
Only estrogen receptors (ERs) have a similar high degree of conservation at the DNA 
binding domain among the two subtypes. The REV-ERBs differ in the N-terminal A/B 
domain and the hinge region. REV-ERB also recognizes the canonical REV-ERB 
motif, which is an AGGTCA half site preceded by an A/T-rich sequence at the 5’ (Dumas 
et al., 1994; Pardee et al., 2009; Woo et al., 2007) (Figure 4.1). Rev-erb is also 
ubiquitously expressed, and has been shown to regulate Bmal1 and ApoC-III, the known 
targets of REV-ERB (Liu et al., 2008a; Wang et al., 2007, 2008), as well as genes 
involved in lipid absorption in skeletal muscle cells (Ramakrishnan et al., 2005). Like 
REV-ERB, REV-ERB also binds heme, which enhances corepressor recruitment and 
transcriptional repression (Pardee et al., 2009; Raghuram et al., 2007). Through heme, 
REV-ERBs can sense the redox state and gas such as O2, NO and CO (Pardee et al., 
2009). In addition, heme binding can be regulated by the redox state of the REV-ERB 
protein (Gupta and Ragsdale, 2011). Other than the above findings, little is known about 
the role of REV-ERBin circadian rhythms and metabolism.  
85 
 
 
4.2b RORs 
The ROR subfamily of nuclear receptors consists of three members: ROR (NR1F1), 
ROR (NR1F2) and ROR (NR1F3). They are classified as orphan receptors, and their 
endogenous ligands are yet to be discovered. Each ROR gene generates several different 
transcripts by using different promoters and/or through alternative splicing, and produces 
isoforms that differ in the N-terminal protein. Each ROR gene and isoform has its own 
distinct profile of tissue-specific expression (reviewed in Jetten, 2009). For instance, 
ROR4 and ROR1 are expressed in liver, and ROR2 (RORt) is expressed specifically 
in T cells (Chauvet et al., 2002; He et al., 1998).  
 
RORs have a typically nuclear receptor structure that contains an N-terminal A/B domain, 
a DNA binding domain, a hinge region and a ligand binding domain. It binds as a 
monomer to the ROR response element, which consists of an AGGTCA nuclear receptor 
half site preceded by an A/T-rich sequence (Carlberg et al., 1994; Forman et al., 1994; 
Giguère et al., 1994; Medvedev et al., 1996). The DNA binding domain of RORs is 65% 
homologous to that of REV-ERBs, the highest among all nuclear receptor subfamily 
(Forman et al., 1994). In consistent with the high homology, RORs have been shown to 
compete with REV-ERBbinding in vitro (Forman et al., 1994), and to regulate the clock 
genes including Bmal1 and Npas2 through the same binding sites as REV-ERBs (Akashi 
and Takumi, 2005; Crumbley et al., 2010; Guillaumond et al., 2005; Takeda et al., 2011) 
(Figure 4.1).  
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Unlike REV-ERBs, RORs have Helix 12, which allows them to interact with coactivators, 
including SRC-1, SRC-2, PGC-1a, p300 and CBP (reviewed in Jetten, 2009). Particularly, 
ROR activates G6pase expression by recruiting SRC-2 and regulates hepatic glucose 
production (Chopra et al., 2008). RORs also interact with corepressors, including NCoR 
and SMRT (reviewed in Jetten, 2009). The transcriptional activity of RORs can be 
regulated by several agonists and antagonists. For instance, 7-oxygenated sterol and 24S-
hydroxycholesterol functions as inverse agonists for RORs by inhibiting coactivator 
recruitment, while a few other hydroxycholesterol functions as agonists by promoting 
coactivator recruitment (Jin et al., 2010; Wang et al., 2010a, 2010b).  
 
RORs play an important role in a variety of physiological processes, including circadian 
rhythms, metabolism and inflammation (reviewed in Jetten et al., 2013). Genetic ablation 
of ROR or ROR causes aberrant circadian behaviors as measured by lomocotor 
activity (Akashi and Takumi, 2005; André et al., 1998). ROR and ROR have been 
shown to regulate Bmal1 and Npas2 expression (Akashi and Takumi, 2005; Crumbley et 
al., 2010; Guillaumond et al., 2005; Takeda et al., 2011). ROR1 expression is directly 
regulated by BMAL1/CLOCK, and exhibits a circadian pattern (Mongrain et al., 2008; 
Takeda et al., 2012).  In metabolism, genetic ablation of ROR downregulates a number 
of lipid metabolic genes, and prevents age- or diet-induced liver steatosis (Kang et al., 
2007; Lau et al., 2008; Raspé et al., 2001). In addition to hepatic lipid metabolism, RORs 
are also involved in glucose metabolism, insulin sensitivity, and metabolism in adipose 
tissue and muscle (reviewed in Jetten, 2009; Jetten et al., 2013).  
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4.3 Results 
4.3a REV-ERB Protects Circadian Rhythms and Metabolic 
Homeostasis from Loss of Rev-erb 
We hypothesized that REV-ERB protects the circadian clock and metabolic homeostasis 
in the Rev-erb deficient mice, which accounts for the modest effects of Rev-erb 
deficiency. REV-ERB is known to bind the same response elements as REV-ERB in 
vitro. Previous studies in our lab revealed that 92% of the REV-ERB ZT10 cistrome 
overlapped with the REV-ERB ZT10 cistrome and that the REV-ERB binding signals 
were highly correlated with that of REV-ERB (r=0.78) (Bugge et al., 2012). The 
cistromic study indicated that REV-ERB shares many gene targets as REV-ERB. 
Gene ontology analysis of genes with at least one shared binding site within 10kb from 
their TSSs revealed enrichment for metabolic processes, within lipid metabolism among 
the top three specialized pathways (Bugge et al., 2012).  
 
Indeed REV-ERB was expressed with a circadian rhythm similar to the rhythm of REV-
ERB. Rev-erb mRNA reached its peak around ZT10/5pm, and reached its trough at 
between ZT18/1am and ZT2/9am (Figure 4.2A), which was consistent with its protein 
(Bugge et al., 2012). Its peak lagged slightly behind that of Rev-erb, which is between 
ZT6/1pm and ZT10/5pm. The genomic binding of REV-ERB was highly correlated 
with its expression level, as shown in the Bmal1 promoter and the Npas2 promoter 
(Figure 4.2B). REV-ERB showed the strongest binding between ZT10/5pm and 
ZT14/9pm, while REV-ERB shows the strongest binding at ZT10/5pm (Figure 4.2C). 
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The similar diurnal rhythm and the strong correlation of REV-ERB and REV-ERB 
binding in mouse liver support that Rev-erb represses many of the same genes as REV-
ERB at the same time of the day.  
 
To test this hypothesis, we depleted hepatic REV-ERB using an adenovirus encoding a 
shRNA sequence targeting Rev-erb (adeno-shRev-erb). Rev-erb mRNA and protein 
levels were down-regulated by at least 80% one week after virus injection [Figure 4.3A 
and (Bugge et al., 2012)]. In Chapter 3, we showed that REV-ERB recruited the NCoR 
corepressor complex and HDAC3 to repress target genes, and observed residual NCoR 
and HDAC3 binding upon loss of Rev-erb. Here we showed that loss of REV-ERB 
also decreased HDAC3 binding at the Bmal1 promoter by approximately 50%, 
comparable to that in the Rev-erb knockout mice (Figure 4.3B). More importantly, 
deficiency of both REV-ERBs further decreased HDAC3 binding (Figure 4.3B), 
indicating that upon loss of either REV-ERB, the remaining one mediates the residual 
recruitment of HDAC3 and continually represses the shared targets. In consistent with the 
loss of HDAC3 binding, Bmal1 is elevated upon loss of REV-ERB, and is further 
elevated upon loss of both REV-ERBs (Figure 4.3A). At the promoter of Npas2, neither 
depletion of REV-ERB or knockout of Rev-erb significantly lowered HDAC3 binding 
(Figure 4.3B), which explained the minimum change in Npas2 expression (Figure 4.3A). 
However, deficiency of both REV-ERBs downregulated HDAC3 binding by 
approximately 50% (Figure 4.3B), leading to a dramatic increase in Npas2 expression 
(Figure 4.3A). In this case, one REV-ERB can almost completely compensate for loss of 
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the other. These findings may explain the modest effects of Rev-erb knockout in both 
circadian rhythms and metabolism.  
 
To test the hypothesis that REV-ERB protects the liver from steatosis upon loss of Rev-
erb, we measured the triglyceride content in the REV-ERB/ depleted liver. One week 
after injection of adeno-shRev-erb, hepatic lipid content in the Rev-erb knockout liver 
was further elevated (Figure 4.4A). Increase in hepatic lipid content was also confirmed 
by Oil Red O staining for neural lipid (Figure 4.4B).  
 
To test the hypothesis that REV-ERB protects the circadian rhythm upon loss of Rev-
erb, we isolated mouse embryonic fibroblasts (MEFs) from both wildtype and Rev-erb 
knockout mice, and treated them with adeno-shRev-erb. Upon serum shock, MEFs with 
normal REV-ERB levels were synchronized and displayed circadian oscillation of the 
clock genes, including Bmal1 and Cry1. Oscillation of Bmal1 and Cry1 was maintained 
when either REV-ERB was depleted, and was completely abolished when both REV-
ERBs were depleted, proving that REV-ERB is protecting the circadian clock in the 
absence of REV-ERB. REV-ERBs are essential components of the core clock 
machinery.  
 
In conclusion, we discovered that REV-ERB displays circadian genomic binding similar 
to REV-ERB and that REV-ERB shares many genomic binding sites and target genes 
with REV-ERB. Moreover, both REV-ERBs repress gene transcription by recruiting 
HDAC3, and are key regulators of the circadian clock and lipid metabolism. The 
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redundancy of REV-ERB and REV-ERB protects circadian rhythms and metabolism, 
and deficiency of both REV-ERBs abolishes circadian rhythms and disrupts metabolic 
homeostasis.  
 
4.3b REV-ERBs Compete with ROR for Genomic Binding at the 
Clock Genes 
We hypothesized that REV-ERBs repress many clock and metabolic genes by directly 
competing with ROR for genomic binding adjacent to these genes, and that competition 
with ROR is crucial for maintaining the circadian rhythm and metabolic homeostasis. 
We first tested this hypothesis at the promoters of two clock genes, Bmal1 and Npas2. 
Previous studies already showed that REV-ERB binds these promoters in a circadian 
manner, with a peak at ZT10 and a trough at ZT22. ROR bound the Bmal1 promoter 
and the Npas2 promoter at ZT22, when both REV-ERBs are absent in liver (Figure 4.6A). 
At ZT10, when REV-ERBs occupy these promoters, ROR binding were largely 
inhibited (Figure 4.6A). The anti-phase rhythm of ROR binding to these promoters, 
despite of the constant expression of ROR(Figure 4.6B), supports the idea that REV-
ERBs compete with and repress RORbinding. Indeed, ROR binding at the Bmal1 
promoter was significantly upregulated when Rev-erb was deleted genetically or when 
REV-ERB was depleted by injection of adeno-shRev-erb, and was dramatically up-
regulated in the absence of both Rev-erbs, to a level close to that at ZT22 (Figure 4.7A), 
but no change was observed in the ROR protein level (data not shown). At the Npas2 
promoter, significant upregulation of ROR binding was only observed in the absence of 
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both Rev-erbs (Figure 4.7A). Changes in ROR binding were consistent with increase in 
gene expression (Figure 4.3A). Moreover, ROR binding showed no increase when 
HDAC3 was deleted in the liver and Rev-erb binding was unaffected (Figure 4.7B), 
suggesting that REV-ERBs suppress ROR binding through direct competition, 
independent of chromatin modification (Figure 4.7C).   
 
4.3c Genome-wide Profile of ROR Binding 
We hypothesized that the competition between REV-ERBs and ROR is not limited to 
Bmal1 and Npas2, but is a genome-wide phenomenon. To test this hypothesis, we 
performed ROR ChIP-seq in mouse liver harvested at ZT10 and ZT22. We performed 
peak calling using HOMER, and identified approximately 13,600 ROR binding sites at 
ZT10, and approximately 20,000 ROR binding sites at ZT22 (Figure 4.8A). Almost all 
of the ROR cistrome (including binding sites at ZT10 and ZT22) was also bound by 
REV-ERB(Figure 4.8B). We then normalized the ROR signal to the total number of 
reads in each dataset, and compared the ROR signal at ZT10 and ZT22 (Figure 4.9A). 
We successfully identified 4740 competing sites where ROR binding increases by at 
least 1.5 fold from ZT10 to ZT22. Many of the competing sites located near clock genes 
including Bmal1, Npas2 and Cry1, metabolic genes including G6pase, Elovl5, Gpam and 
Hmgcs2, and metabolic regulators including PGC-1, E4bp4 and Insig2 (data not shown). 
The competing sites are only a small fraction of the ROR cistrome. We also identified 
7520 non-competiting sites (less than 1.2 fold difference between ZT10 and ZT22) and 
2486 in-phase sites (at least 1.5 fold decrease from ZT10 to ZT22). Among the 
92 
 
competing sites are the Bmal1 promoter (Figure 4.9B) and the Npas2 promoter. ROR 
binding at six selected binding sites was validated with ChIP-PCR (Figure 4.10A) and 
also with another ROR antibody recognizing a different epitope (Figure 4.10B). 
Binding sites 1-3 are competing sites, and binding sites 4-6 are non-competing sites. All 6 
bindings are indeed specific to ROR, as ROR binding at these sites was significantly 
decreased in the ROR sg/sg mice carrying a nonsense mutation in the ROR gene 
(Figure 4.10C, D).  
 
We then compared REV-ERB binding at the competing sites, non-competing sites and 
in-phase sites, and found that REV-ERB binding oscillated with similar amplitudes in 
all three groups (Figure 4.9C). To understand the mechanisms that account for different 
RORbinding rhythms, we performed de novo motif analysis on the competing sites 
using the non-competiting sites as control. The top two motifs found were a DR2 nuclear 
receptor motif, which is a direct repeat of the nuclear receptor half sites separated by two 
nucleotides and a canonical ROR/REV-ERB motif, which is a nuclear receptor half 
site preceded by A/T-rich sequence (Figure 4.11A). Both motifs occurred at a 
significantly higher frequency in the competing sites compared with the non-competing 
or in-phase sites (Figure 4.11B). They were also significantly enriched near the center of 
the ROR peaks, and the enrichment was much higher in the competing sites (Figure 
4.11C, D). These findings suggest that competition between ROR and REV-ERBs is 
more likely to occur at genomic regions with desired DNA sequences and high affinity 
for ROR and REV-ERBs, and agree with our hypothesis that ROR and REV-ERBs 
compete for the same binding motif in vivo. Moreover, the DR2 motif was enriched at the 
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center of the competing sites, but barely at the center of non-competing or in-phase sites 
(Figure 4.11D). This may be explained by the in vitro finding that REV-ERB binds the 
DR2 motif as a homodimer, 5 to 10 times more stable than REV-ERB monomer 
binding to the ROR motif (Harding and Lazar, 1993). The strong binding at the DR2 
motif by REV-ERBs can better prevent ROR binding.  
 
4.3d Overexpression of ROR Fails to Overcome REV-ERB 
Competition  
To further test the hypothesis that REV-ERBs suppress ROR binding through direct 
competition, we overexpressed ROR4, the dominant ROR isoform in liver, using an 
adeno-associated virus encoding the ROR4 cDNA (AAV-ROR4). Two weeks after 
virus injection, we observed a 15 fold increase in the ROR4 transcript (Figure 4.12A). 
ROR4 overexpression increased ROR binding at ZT22 at all four binding sites when 
Rev-erb is absent, including two new sites identified by ChIP-seq (Figure 4.12B), but 
failed to overcome REV-ERB suppression at ZT10 at Bmal1, Npas2 and the ROR 
binding site 3, a competing site. In consistent with unchanged ROR binding, ROR4 
overexpression failed to induce Bmal1 or Npas2 expression at ZT10 (Figure 4.12A). Our 
results suggest that REV-ERBs might have a higher affinity for the competing sites, and 
dominate in the competition with ROR. At the ROR binding site 4, a non-competing 
site, the increased ROR level doubled the ROR binding at both ZT10 and ZT22 
(Figure 4.12B), supporting our model that REV-ERBs do not compete with RORat 
these sites.  
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4.3e ROR Binding Correlates with Histone Acetylation 
Nuclear receptors regulate transcription through recruiting coactivator and corepressor 
complexes. Coactivator complexes usually contain histone acetyltransferases (HATs), 
such as p300 and CBP. ROR has been shown to recruit p300 in muscle and coactivator 
SRC-2 in liver (Chopra et al., 2008; Lau et al., 1999). We discovered that p300 
recruitment to the ROR binding sites correlates with the rhythmic ROR binding 
(Figure 4.13A). We observed rhythmic p300 recruitment only at the competing sites, but 
not at the non-competing sites. Moreover, the rhythmic p300 recruitment at the 
competing sites may allow a more robust oscillation in histone acetylation, in comparison 
with the non-competing sites (Figure 4.13B). Our findings suggest that in addition to 
HDAC3 recruitment, REV-ERBs may also control histone acetylation by repressing 
ROR-mediated recruitment of p300. 
 
4.4 Discussion and Future Directions 
In consistent with our finding that REV-ERB protects circadian rhythms in the absence 
of REV-ERB, Evans and colleagues showed that Rev-erb and Rev-erb double 
knockout mice become arrhythmic in constant darkness. So far every single component 
of the core clock machinery has been deleted genetically in mouse. Except for Bmal1 
deletion (Bunger et al., 2000), none of the single mutation rendered mice arrhythmic in 
constant darkness, though most of them did affect the rhythm to some extent (Cermakian 
et al., 2001; DeBruyne et al., 2006; Dudley et al., 2003; van der Horst et al., 1999; 
Vitaterna et al., 1999; Zheng et al., 1999, 2001). Even the Bmal1 deletion can be 
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compensated by ectopic expression of Bmal2 (Shi et al., 2010). In contrast, 
combinational deletion of the redundant components completely abolished the circadian 
rhythms, such as the double deletion of Clock and Npas2, Cry1 and Cry 2, Per1 and Per2, 
and Rev-erb and Rev-erb (Bae et al., 2001; Cho et al., 2012; DeBruyne et al., 2007; 
van der Horst et al., 1999; Vitaterna et al., 1999; Zheng et al., 2001). Together, these 
studies demonstrate the unusual redundancy of the core clock components. The circadian 
rhythm is so critical for survival that every component in the clock machinery needs a 
backup.  
 
Although the paralogs in the circadian clock are redundant in maintaining circadian 
rhythms, they may be regulated differently and have different functions in circadian 
outputs. Our study showed that REV-ERB and REV-ERB have almost identical 
genomic binding profiles and rhythms and a similar role in preventing hepatosteatosis. 
But they may behave differently in response to environmental signals. It may be 
interesting to see if the Rev-erb-deficient mice and the Rev-erb-deficient show 
different response to light exposure or fasting/feeding. Also we should look into other 
tissues to see if the two REV-ERBs have different roles in regulating other physiological 
activities.  
 
We identified three different types of ROR binding sites based on their binding rhythms: 
the competing sites, the non-competing sites and the in-phase sites. For the competing 
sites, as represented by the Bmal1 promoter and the Npas2 promoter, we showed that 
REV-ERBsrepress ROR binding at ZT10 and drive a rhythmic ROR binding in 
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mouse liver. These binding sites are more likely to contain the ROR motif and the 
REV-ERB DR2 motif, suggesting that competition happens in the genomic region with 
desired DNA sequences that allow specific and strong binding of ROR and REV-ERB. 
We also discovered that rhythmic ROR binding correlates with p300 recruitment and 
contributes to the robust oscillation of histone acetylation at the competing sites. Our 
findings all agreed with our hypothesis that REV-ERBs drive circadian histone 
acetylation and gene expression through competing with ROR. We still need to address 
whether p300 recruitment is dependent on ROR. 
 
So far, we have not addressed the biological significance of ROR. Previous studies in 
our lab showed that loss of HDAC3 does not abolish circadian rhythms as tested in MEFs 
and in liver (data not shown). Since the active repression model cannot account for all the 
activities of REV-ERBs, we hypothesized that passive repression through RORalso 
plays an important role in regulating circadian rhythms and metabolic activities. In 
consistent with our hypothesis, we found competing sites near clock genes including 
Bmal1, Npas2 and Cry1, metabolic genes including G6pase, Elovl5, Gpam and Hmgcs2, 
and metabolic regulators including PGC-1, E4bp4 and Insig2 (data not shown). 
Disregulation of circadian and metabolic gene expression has been shown in the livers of 
the ROR sg/sg mice (Kang et al., 2007; Takeda et al., 2012). However, these mice 
suffer from severe impairment of orientation and motor capabilities and have significant 
lower weight compared to the WT mice, and therefore are not a good model to study the 
function of ROR in circadian rhythms and liver metabolism. Instead, we will use a 
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ROR conditional knockout model and delete ROR specifically in liver by injection of 
the AAV-Cre virus.  
 
ROR1 is also expressed in liver, and its transcript level is comparable to that of 
ROR(data not shown). Unlike ROR, ROR1 shows circadian expression at the 
transcript level, which has not been validated at the protein level (Mongrain et al., 2008). 
Given that ROR1 is expressed anti-phase to REV-ERBs, competition between REV-
ERBs and ROR1 may not exist or has little effect on ROR1 activity. However, ROR1  
may compensate for the loss of ROR in liver. Therefore we will cross the ROR 
conditional knockout mice with the ROR conditional knockout mice to generate the 
ROR/ROR double conditional knockout mice to test the function of RORs in circadian 
rhythms and metabolism. Moreover, we may also discover non-overlapping functions of 
ROR and ROR 
 
So far our studies have been focusing on the competing sites. However, it is also 
important to understand why REV-ERBs do not compete with ROR at the non-
competing sites. ChIP-PCR showed relatively weak but real binding of RORat the non-
competing sites (Figure 4.10), and binding was doubled upon ROR overexpression at 
both ZT10 and ZT22. There may be two explanations for our observations. First, REV-
ERBs and RORmay bind to two different motifs adjacent to each other. We can test 
this hypothesis by measuring the peak distance between the overlapping ROR and 
REV-ERB binding sites in the non-competing sites and comparing it to that in the 
competing sites. We can also try to identify multiple nuclear receptor motifs within the 
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non-competing sites. The second explanation is that the non-competing sites contain less 
than perfect motifs and have an open chromatin structure so that nuclear receptors like 
ROR and REV-ERBs can bind to them transiently and do not compete with each other. 
But such transient binding may not be important for gene regulation.  
 
It is also intriguing that ROR is recruited in-phase with REV-ERBs at many sites and 
that these sites are significantly enriched for GR motif (Figure 4.11B, E). Obviously we 
need to validate the ROR binding at these sites. But it is interesting to see that GR 
binding is indeed enriched at these sites compared with the competing and non-
competing sites (Figure 4.14). GR is stably expressed in liver, but its genomic binding 
and transcriptional activity is regulated by ligands, such as corticosterone. The plasma 
corticosterone level fluctuates with a peak between ZT10 and ZT14 and a trough between 
ZT20 and ZT24 (Oster et al., 2006). This explains our finding that GR binds to the mouse 
liver genome with a rhythm that is high at ZT10 and low at ZT22 (data not shown). We 
thus hypothesized that GR contributes to the in-phase binding of ROR. It is known that 
daily injection of glucocorticoid can drive the oscillation of 60% of the circadian 
transcriptome in liver, and it is possible that ROR is involved in this process. Once we 
validate the in-phase binding of ROR, we can test the GR hypothesis by activating GR 
binding at ZT22 with dexamethasone injection.  
 
We reported that competition exists between REV-ERBs and ROR, but it may also exist 
between REV-ERBs and another nuclear receptor, such as PPAR, or between two other 
nuclear receptors. Mandrup and colleagues recently reported that PPAR binds to over 
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70% of the LXR sites in mouse liver, and binding of PPAR and LXR are mutually 
exclusive (Boergesen et al., 2012). Therefore, it may be interesting to compare the ROR 
cistrome and the REV-ERB cistrome we have with the public available cistromes of other 
nuclear receptors.  
 
Recent advances in the next generation sequencing technology allowed scientists to 
accurately map the genome-wide binding of a large number of transcription factors in a 
variety of cell lines and tissues from different organisms. Comparing the transcription 
factor maps led to surprising findings that transcription factor binding is highly tissue-
specific, and that in the same tissue or cell line, many transcription factors share a large 
number of genomic regions. For instance, Mandrup and colleagues recently reported that 
CEBP, STAT5a and GR co-occupy ‘hotspots’ characterized by an open chromatin 
structure and specific epigenetic modifications in early adipogenesis (Siersbæk et al., 
2011). Pu and colleagues showed that several cardiac transcription factors, including 
GATA4, NKX2-5, MEF2A, TBX5 and SRF, co-occupy many genomic regions (He et al., 
2011). Ng and colleagues discovered hundreds of multiple-transcription factor binding 
sites in embryonic stem cells (Chen et al., 2008). The modENCODE consortium reported 
high occupancy target (HOT) regions that are occupied by at least 15 transcription factors 
in C. elegans or by at least 8 transcription factors in Drosophila (Gerstein et al., 2010; 
Nègre et al., 2011). The molecular mechanisms and the biological significance of co-
occupancy by transcription factors remain to be explored.  
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Figure 4.1 REV-ERBs and RORs Share Many Genomic Binding Sites. REV-ERBs 
and RORs recognize the same binding motif and share many gene targets including 
Bmal1 and Npas2.   
(A/T)AGGTCA 
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Figure 4.2 Circadian Expression and Genomic Binding of REV-ERB in Mouse 
Liver.  
A. Rev-erb and Rev-erb mRNA levels in the livers of 12 week old C57Bl/6 mice 
housed in a 24h cycle. Values are mean ± s.e.m (n=5).  
B. REV-ERB recruitment at the Bmal1 promoter and the Npas2 promoter over a 24h 
cycle as interrogated by ChIP-PCR. Immunoprecipitated DNA was normalized to input. 
Values are mean ± s.e.m (n=3-4).  
C. REV-ERB recruitment at the Bmal1 promoter and Npas2 promoter over a 24h cycle 
as interrogated by ChIP-PCR. Values are mean ± s.e.m (n=3-4).  
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Figure 4.3 REV-ERB Compensates for Loss of REV-ERB and Represses Clock 
Genes.  
A. Gene expression in livers from 12 week old male WT or Rev-erb knockout () 
mice one week after injection of adeno-shRev-erb (shRev) or adeno-shGal (shGal) 
as control. Values are mean ± s.e.m (n=4-6). *p<0.05 by student t-test.  
B. HDAC3 recruitment in livers as in A as interrogated by ChIP-PCR. Values are mean ± 
s.e.m (n=3). *p<0.05 by student t-test.  
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Figure 4.4 REV-ERB Prevents Liver Steatosis from Loss of REV-ERB.  
A. Hepatic TG levels in livers from 12 week old male WT or Rev-erb knockout () 
mice one week after injection of adeno-shRev-erb (shRev) or adeno-shGal (shGal) 
as control. Values are mean ± s.e.m (n=5-7). *p<0.05 by student t-test.  
B. Oil Red O staining of liver from 12 week old male WT or Rev-erb knockout () 
mice one week after injection of adeno-shRev-erb (shRev) or adeno-shGal (shGal) 
as control. 
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Figure 4.5 REV-ERB Protects the Circadian Clock from Loss of REV-ERB.  
Gene expression in synchronized WT or Rev-erb knockout (KO) MEFs infected with 
adeno-shRev-erb (shRev) or adeno-shGal (shGal) as control. Values are mean ± 
s.e.m (n=3). All values have been normalized to Arbp expression and the 8 hr time point 
in the WT control. 
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Figure 4.6 Diurnal Binding of ROR  
A. Diurnal recruitment of ROR to the Bmal1 promoter and the Npas2 promoter was 
shown by ChIP-PCR.  The region close to the TSS of the Arbp gene served as a negative 
control. Values are mean ± s.e.m. (n=4-5).  
B. ROR mRNA levels in the livers of 12 week old C57Bl/6 mice housed in a 24h cycle. 
Values are mean ± s.e.m (n=5). 
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Figure 4.7 REV-ERBs Repress ROR Binding.  
A. ROR recruitment to the Bmal1 promoter and the Npas2 promoter was upregulated in 
the absence of REV-ERB and/or REV-ERB.  ROR recruitment in livers from 12 
week old male WT or Rev-erb knockout () mice one week after injection of adeno-
shRev-erb (shRev) or adeno-shGal (shGal) was interrogated by ChIP-PCR. Values 
are mean ± s.e.m (n=4-5). *p<0.05 by student t-test. 
B. ROR recruitment to the Bmal1 promoter and the Npas2 promoter was unaffected in 
the absence of HDAC3. REV-ERB and ROR recruitment in livers from the HDAC3fl/fl 
mice 1 week after injection of the AAV-Cre virus was interrogated by ChIP-PCR. AAV-
GFP virus was used as a negative control. Values are mean ± s.e.m (n=4).  
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Figure 4.8 ROR Cistrome in Liver at ZT10 and ZT22. 
A. Comparison of HDAC3 binding sites at ZT10 (Blue) and ZT22 (Red).  Peak calling 
was performed with HOMER. A pair of ZT10 and ZT22 binding sites (approximately 
200bp wide) was considered overlapping when they have at least 1bp in common.  
B.  Heatmap of ROR and REV-ERB binding signal at ZT10 and ZT22 from -1kb to 
+1kb surrounding the center of all the ROR and REV-ERB binding sites. Each line 
represents a single binding site and the color scale indicates the binding signal (read 
density in ChIP-seq data).  
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Figure 4.9 Identify Competing, Non-competing and In-phase Binding Sites. 
A. Scatter plot of ROR binding signals at ZT10 (x-axis) and ZT22 (y-axis) in log scale.  
Competing (Red), no-competing (Blue) and in-phase (Green) sites were identified based 
on the fold changes of signals from ZT10 to ZT22.  
B. The Bmal1 promoter was identified as a competing site. Peak height correlates with 
the REV-ERB (Red) or ROR (Green) ChIP-seq signal at ZT10 or ZT22.  
C. Average ROR and REV-ERB binding signals surrounding the center of the 
competing, non-competing and in-phase sites at ZT10 and ZT22. The signals were 
represented by the read density in ChIP-seq data.  
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Figure 4.10 Validation of ROR Binding Sites.  
A. B. ROR recruitment at ZT10 and ZT22 as shown by ChIP-PCR with two different 
ROR antibodies C-16 (A) and H-65 (B). Six ROR binding sites were interrogated, 
including 3 competing sites (1-3) and 3 non-competing sites (4-6). The Bmal1 gene 
promoter and the Npas2 promoter were used as positive controls, and the region close to 
the Arbp TSS as a negative control. Values are mean ± s.e.m. (n=4).  
C. D. ROR recruitment at ZT22 in livers from WT mice or the ROR sg/sg mice as 
shown by ChIP-PCR with two different ROR antibodies C-16 (C) and H-65 (D).  
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Figure 4.11 Motif Analysis of the ROR Binding Sites. 
A. Three motifs identified in motif analysis of the competing, non-competing and in-
phase binding sites. 
B. Percentage of bindings sites with either ROR, DR2 or GR motif as shown in A 
among the competing (Red), non-competing (Yellow) and in-phase (Green) binding sites.  
C. D. E. Density of the ROR (C), DR2 (D) and GR (E) motif surrounding the center of 
the competing (Red), non-competing (Yellow) and in-phase (Green) binding sites.  
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Figure 4.12 Overexpression of ROR Fails to Overcome REV-ERB Competition.  
A. ROR, Bmal1 and Npas2 expression in livers harvested at ZT10 and ZT22 from 12 
week old C57Bl/6 mice 2 weeks after injection of AAV-ROR4 or AAV-GFP (control). 
Values are mean ± s.e.m (n=3). 
B. ROR recruitment in livers harvested at ZT10 and ZT22 from 12 week old C57Bl/6 
mice 2 weeks after injection of AAV-ROR4 or AAV-GFP (control). Values are mean ± 
s.e.m (n=3). *p<0.05; #p~0.05.  
 
  
04
812
1620
RORa
ZT10 AAV-GFP
ZT10 AAV-RORa4
ZT22 AAV-GFP
ZT22 AAV-RORa4
0
4
8
12
16
20
RORa
G
e
n
e
 e
x
p
re
s
s
io
n
  
(r
e
la
ti
v
e
 t
o
 A
rb
p
) 
0
4
8
12
16
20
Bmal1
0
40
80
120
160
200
240
NPAS2
A 
 
0
0.4
0.8
1.2
NPAS2
0
0.5
1
1.5
2
2.5
Arbp Bmal1 Npas2 3 4
P
e
rc
e
n
ta
g
e
 o
f 
In
p
u
t 
(%
) 
ROR ChIP 
ZT10 AAV-GFP
ZT10 AAV-RORa4
ZT22 AAV-GFP
ZT22 AAV-RORa4
B 
 
* 
* 
* 
* 
# # 
113 
 
 
Figure 4.13 ROR Binding Is Associated with p300 Recruitment and Histone 
Acetylation.  
A. p300 recruitment at ZT10 and ZT22 as shown by ChIP-PCR at six ROR binding 
sites, including 3 competing sites (1-3) and 3 non-competing sites (4-6). The Bmal1 gene 
promoter and the Npas2 promoter were used as positive controls, and the region close to 
the Arbp TSS as a negative control. Values are mean ± s.e.m. (n=4).  
B. Average H3K9Ac signal from -2kb to +2kb surrounding the center of all the 
competing (Left) and non-competing sites (Right). The Y axis represents the H3K9Ac 
signal (read density).  
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Figure 4.14 In-phase ROR Binding sites Are Enriched for GR binding. Average 
GR binding signal at ZT10 from -1kb to +1kb surrounding the center of all the competing 
(Red), non-competing sites (blue) and in-phase (Green) sites. The Y axis represents the 
GR signal (read density). 
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Chapter 5 
Future Directions 
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5.1 Summary 
My study suggests that REV-ERB and REV-ERB direct a circadian rhythm in histone 
acetylation and gene expression that is required for hepatic homeostasis in liver, by 
recruiting histone deacetylase HDAC3 or suppressing ROR and histone acetylase 
recruitment. In Chapter 3, I showed that histone deacetylase 3 (HDAC3) recruitment to 
the genome displays a circadian rhythm in mouse liver.  Histone acetylation is inversely 
correlated to HDAC3 binding, and this rhythm is lost in the absence of HDAC3.  
Although protein amounts of HDAC3 are constant in liver, its genomic recruitment 
corresponds to the expression pattern of the circadian nuclear receptor REV-ERB.  I 
demonstrated that REV-ERB is required for HDAC3 recruitment at many HDAC3 
binding sites. I found that REV-ERB colocalizes with HDAC3 near genes regulating 
lipid metabolism, and deletion of HDAC3 or REV-ERB in mouse liver causes hepatic 
steatosis.  Therefore, I propose that the genomic recruitment of HDAC3 by REV-ERB 
directs a circadian rhythm of histone acetylation and gene expression required for normal 
hepatic lipid homeostasis. 
 
In Chapter 4, I examined the role of REV-ERB and ROR, two nuclear receptors that 
are closely related to REV-ERB. Rev-erb deletion has modest effects on both 
circadian rhythms and lipid metabolism. Here I reported that REV-ERB displays 
circadian recruitment to the Bmal1 and Npas2 genes, similar to that of REV-ERB. 
Depletion of REV-ERB in Rev-erb null liver further decreases HDAC3 recruitment, 
derepresses Bmal1 and Npas2 expression, and exacerbates hepatic steatosis. I also 
showed that loss of both REV-ERBs abolishes the circadian rhythm in mouse embryonic 
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fibroblasts. Our findings established the two REV-ERBs as major regulators of both 
clock function and hepatic metabolism.  
 
In the second half of Chapter 4, I reported that ROR binds the Bmal1 and Npas2 genes 
with a diurnal rhythm anti-phase to that of REV-ERBs. I showed that REV-ERBs repress 
ROR binding at ZT10 and thus drives the diurnal recruitment of ROR, which is 
expressed at constant levelsRepression by REV-ERBs is independent of HDAC3, 
suggesting that REV-ERBs represses ROR binding through direct competition. I then 
identified thousands of competing sites similar to those in Bmal1 and Npas2 genes by 
ROR ChIP-seq at ZT10 and ZT22, many of which are in close proximity of clock and 
metabolic genes. ROR function in circadian rhythms and hepatic metabolism will be 
tested in mouse models of liver-specific deletion of ROR and its paralog ROR. I also 
discovered thousands of ROR binding sites with no rhythmic ROR binding, and sites 
where ROR bind is in phase with REV-ERBs. How ROR recruitment is regulated at 
these non-competing or in-phase sites remains to be elucidated.  
 
5.2 Future Directions 
So far I have shown that REV-ERBs direct circadian recruitment of HDAC3 and ROR, 
drive rhythmic histone acetylation, and contribute to circadian lipid biosynthesis and lipid 
homeostasis in liver. Although evidence suggests that diurnal recruitment of HDAC3 is 
regulated by the liver clock, which is the core clock machinery in hepatocytes, I have not 
yet demonstrated that HDAC3 recruitment is truly ‘circadian’ and is sustained in the 
absence of food intake. In addition, I have focused on how the liver clock regulates 
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metabolism, but not yet investigated how the metabolic state and metabolites regulate the 
clock through REV-ERBs. In the next step, I will explore how REV-ERB activity is 
modulated in liver, particularly by metabolic signals. In Chapter 3, I suggested that REV-
ERBs and HDAC3 may be involved in the development of fatty liver disease in human 
caused by circadian misalignment, such as rotating shift work and jet-lag. I would like to 
test this hypothesis, and explore how circadian misalignment is associated with increased 
risk of metabolic diseases in human. Last but not least, I would like to investigate the 
non-redundant functions of REV-ERB and REV-ERB, and further explore HDAC3 
function in circadian rhythms.  
 
5.2a Diurnal Recruitment of REV-ERBs and HDAC3—Clock or Food? 
As I discussed in Section 1.5, the oscillating liver transcriptome (the once called 
‘circadian’ transcriptome) is the result of the oscillating liver clock and the 
fasting/feeding cycles. Usually the feeding behavior is aligned with the liver clock, and 
they work together to drive rhythmic gene expression and metabolic activities. In the 
absence of feeding or food intake, most of the ‘circadian’ liver transcripts can no longer 
oscillate. In Chapter 3, I showed that the diurnal recruitment of HDAC3 is sustained in 
constant darkness but was reversed when restricted feeding reset the liver clock (Figure 
3.6). These findings suggest that HDAC3 recruitment is regulated by the liver clock, the 
core clock machinery in hepatocytes. However, in both cases, the liver clock was still 
aligned with fasting/feeding cycles, and they could both contribute to the diurnal 
recruitment of HDAC3. Is the cyclic REV-ERB and HDAC3 recruitment driven solely by 
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the circadian clock or is it also regulated by food intake? To answer this question, I 
proposed the following experiments.  
 
To prove that the cyclic REV-ERB and HDAC3 recruitment is driven by the circadian 
clock, I will isolate and synchronize mouse primary hepatocytes, and ask if the diurnal 
REV-ERB and HDAC3 recruitment sustains in a cell-autonomous manner. But this in 
vitro model has one major disadvantage that the isolated hepatocytes cannot maintain the 
differentiated state and quickly lose their metabolic capacity. Therefore, we may not be 
able to study how REV-ERBs and HDAC3 regulate metabolic genes and metabolic 
activities in these cells. 
 
The second experiment was to test whether the diurnal recruitment of REV-ERBs and 
HDAC3 is sustained in the absence of food intake in vivo. In this experiment, mice were 
fasted from ZT10, and a subset of them was refed 18 hours later at ZT4. We interrogated 
REV-ERB and HDAC3 recruitment in mouse liver at ZT22 (12-hour fasting) and at the 
next ZT10 (24-hour fasting or 6-hour refeeding after 18-hour fasting) (Figure 5.1A). In 
the absence of food (fasting), I observed significant increase in HDAC3 recruitment at 
ZT22 in most of the sites we tested, including the Bmal1 promoter, but the diurnal 
rhythm of HDAC3 recruitment was partially sustained (Figure 5.1C). This result 
indicates that diurnal HDAC recruitment is driven at least partially by the liver clock. 
REV-ERB recruitment was also increased significantly at many sites, suggesting that 
REV-ERB may contribute to the increase in HDAC3 recruitment (Figure 5.1B). 
However, the increase in REV-ERB recruitment was much smaller than that in HDAC3 
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recruitment, and this difference may be explained by enhanced HDAC3 recruitment by 
REV-ERB upon fasting or by transcription factors other than REV-ERBs. On the 
contrary, feeding seems to decrease REV-ERB and HDAC3 recruitment. I observed a 
significant decrease in both HDAC3 and REV-ERB binding at ZT10 in the livers of the 
refed mice (Figure 5.1B,C). Together, these findings show that rhythmic REV-ERB and 
HDAC3 recruitment is regulated by the liver clock and by fasting/feeding. So far, I have 
only interrogated a small set of HDAC3 binding sites by ChIP-PCR, and observed 
different responses to fasting/feeding among these sites. I plan to expand my study 
genome-wide using ChIP-seq. I will also try to understand how REV-ERB and HDAC3 
recruitment is regulated by fasting/feeding and test whether changes in HDAC3 
recruitment is independent of REV-ERBs.  
 
5.2b Modulation of REV-ERB Activity 
So far, I have established the essential role of REV-ERBs in circadian rhythms and 
demonstrated a pivotal role of REV-ERBs in regulation of liver metabolism by the 
circadian clock. The next step is to understand how REV-ERB activity is modulated by 
metabolic signals and others. As I discussed in Section 1.4, the crosstalk between 
circadian clocks and metabolism is not unidirectional, and metabolic signals can regulate 
clock gene expression and the transcription activity of the clock proteins (Figure 1.5). 
The feedback regulation is critical for metabolic homeostasis and fine tuning of the clock 
function. The role of REV-ERB in this process remains to be explored. 
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First, heme is a REV-ERB ligand Yin et al., 2007). In vitro study showed that REV-
ERB structure and corepressor recruitment can be regulated by the intracellular redox 
state and gases such as O2, NO and CO through heme (Pardee et al., 2009; Yin et al., 
2007). This suggests that heme binding to REV-ERB may have important regulatory 
functions on circadian rhythms and hepatic metabolism. Does loss of heme binding really 
inhibit HDAC3 recruitment by REV-ERB in vivo, and affect the clock and metabolic 
gene expression and lipid homeostasis? To answer this question, I plan to inhibit heme 
biosynthesis by suppressing the rate-limiting enzyme ALAS1 in mouse liver, and 
examine HDAC3 genomic recruitment, clock and metabolic gene expression and liver 
triglyceride in response to decrease in heme levels. Secondly, REV-ERB protein 
stability and abundance is regulated by phosphorylation and ubiquitination. Is the post-
translational regulation important for circadian REV-ERB expression in mouse liver? 
This question can be addressed by ectopic expression of wildtype REV-ERB or mutant 
REV-ERB with serine to alanine mutations at varies phosphorylation sites. If my 
hypothesis is correct, I should observe oscillation in ectopically expressed wildtype REV-
ERB, and should find little or no mutant REV-ERB in liver. Previously I showed that 
REV-ERB binding was significantly down-regulated in the refed mice (Figure 5.1B). 
Does REV-ERB protein level decrease? Is it through post-translational modification? I 
can address this question by measuring REV-ERB protein levels and GSK3 activation 
in these livers.  
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5.2c Circadian Disruption and Liver Steatosis 
Circadian clocks in our bodies synchronize metabolic events with our daily activity 
cycles, and therefore ensure the energy supply and maintain the internal homeostasis. But 
this delicate system has been increasingly challenged in modern society. Circadian 
rhythm disorders have been observed in a large population due to rotating shift work, jet-
lag, night eating, sleep disruption and deprivation, and many epidemiological studies 
have shown that circadian rhythm disorders lead to a higher risk of metabolic diseases, 
including obesity, diabetes and non-alcoholic fatty liver disease. In recognition of these 
concerns, the Lazar lab studies the crosstalk of circadian clocks and metabolism through 
REV-ERBs, HDAC3s and RORs, and hopes to understand the pathogenic processes of 
metabolic disorders caused by circadian rhythm disorders/circadian misalignment.   
 
In Chapter 3, I proposed that misalignment of fasting/feeding and sleep/wake cycles with 
endogenous circadian cycles could disrupt rhythmic HDAC3 association with lipid 
metabolic genes and contribute to the fatty liver observed in rotating shift workers as well 
as people with genetic variants of clock genes (Brunt, 2010; Sookoian et al., 2007). 
However, we do not have any evidence that circadian misalignment or genetic mutation 
of clock genes affects the circadian binding of HDAC3 and causes liver steatosis. And I 
plan to test this hypothesis using mouse models mimicking human circadian rhythm 
disorders or genetic mutation of clock genes.  
 
In collaboration with Dr. Loning Fu at Baylor College of Medicine, I first studied a 
chronic jet-lag mouse model. Jet lag is a physiological condition that results from rapid 
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long-distance transmeridian travel (typically by jet). After landing in a new time zone, the 
circadian clock of the passenger is misaligned with the destination time. Both jet lag and 
shift work cause circadian misalignment, affect the body clock, and result in similar 
symptoms such as fatigue and loss of appetite (Waterhouse, 1999).  In our model, mice 
were treated with chronic back-and-forth jet-lag since 4 weeks of age. At the beginning 
of each week, the light/dark cycle was advanced by 8 hours and stayed for 3 days, and 
was switched back and stayed for 4 days (Figure 5.2A). Consistent with the 
epidemiological evidence that shift workers may have a higher risk of liver steatosis, we 
observed a significant increase in liver triglyderide in the jet-lag mice 3 weeks after the 
treatmenet (data not shown, provided by Dr. Loning Fu). In the livers from the jet-lag 
mice, HDAC3 still binds genome sites at both ZT10 and ZT22, but the diurnal binding 
rhythm was completely abolished (Figure 5.1C). HDAC3 binding in the jet-lag mice at 
both ZT10 and ZT22 was lower than that at ZT10 in control mice, but higher than that at 
ZT22 in control mice. The intermediate binding of HDAC3 in the jet-lag mice was 
consistent with the intermediate expression of both REV-ERBs (Figure 5.2B). Using the 
jet-lag mouse model, I showed that chronic circadian misalignment impaired the 
circadian clock, abolished diurnal HDAC3 recruitment and caused liver steatosis.  
 
I also tested my hypothesis with Cry1/2 double knock mice (Cry DKO), in which 
circadian rhythms are completely abolished (Van der Horst et al., 1999). These mice also 
showed a significant increase in liver fat content (data not shown, provided by Dr. Loning 
Fu). REV-ERB binding rhythm was abolished, as gene expression no long oscillated in 
these mice (Figure 5.3A, B). Since HDAC3 is recruited by REV-ERBs, it too lost the 
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binding rhythm (Figure 5.3C). Here I showed that genetic mutation of the clock genes 
abolished diurnal HDAC3 recruitment and caused liver steatosis.  
 
My studies on the jet-lag mice and the Cry DKO mice demonstrate that circadian 
misalignment or genetic mutation of clock genes affects the circadian binding of HDAC3 
and causes liver steatosis. However, I have not yet been able to prove the cause and effect 
relationship between loss of rhythmic HDAC3 and REV-ERB binding and fatty liver. To 
establish the cause-and-effect relationship, I propose the following studies.  
 
First, I will test whether loss of the liver circadian rhythm causes liver steatosis. Both 
chronic jet-lag and Cry1/2 double knockout impair the central clock and the peripheral 
clocks, and alter both behaviors and physiology. To focus on the liver clock, I will create 
a mouse model in which only the liver clock is “jet-lagged”. A preliminary idea is to 
provide food only for 4 hours a day, and at the beginning of each week advance the 
feeding time for 8 hours and switch back 3 days later. The back-and-forth shift in timely 
restricted feeding should impair the rhythmic expression of clock genes in major 
metabolic organs, particularly liver, yet have no minimum effects on the central clock. I 
will then test whether the feeding regimen abolishes HDAC3 recruitment rhythm, affects 
circadian and metabolic gene expression, and causes increase in liver triglyceride content.  
 
The key experiment to establish the cause-and-effect relationship is to ectopically express 
REV-ERB and/or REV-ERB in liver to a stable intermediate level observed in the jet-
lag mice. To eliminate the effects of endogenous REV-ERBs, I will perform this 
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experiment in mice with genetic deletion of both Rev-erb/ in liver. These mice will be 
housed under regular light/dark cycles and allowed free access to food. If liver 
triglyceride is increased in mice with a stable intermediate level of REV-ERB, we may 
conclude that circadian misalignment abolishes rhythmic HDAC3 and REV-ERB binding, 
and thus leads to fatty liver. And this finding will strongly support the role of HDAC3 
and REV-ERBs in the development of non-alcoholic fatty liver disease in human with 
circadian rhythm disorders.  
 
In summary, my studies using the chronic jet-lag mouse model and the Cry DKO model 
agree with the hypothesis that the impaired HDAC3 binding rhythm is involved in the 
pathogenesis of fatty liver caused by circadian disruption. These mouse models mimic 
circadian misalignment in human, and therefore may provide useful insights into the 
onset of human fatty liver disease. 
 
5.2d Non-redundant Roles of REV-ERB and REV-ERB 
In Chapter 4, I showed that REV-ERB and REV-ERB have almost identical roles in 
transcriptional regulation, and overlapping functions in circadian rhythms and hepatic 
lipid metabolism. As a result, I have always been asked if these two always share the 
same role. The answer may be ‘No’. First, REV-ERB and REV-ERB have slightly 
different expression rhythms. Although they mostly bind the same genomic regions and 
are likely to share the same gene targets in liver, they may repress these targets at slightly 
different times of the day. Secondly, REV-ERB and REV-ERB may be expressed at 
different abundance in liver. Therefore, one may be more important than the other in the 
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liver clock and liver metabolism. Last, REV-ERB and REV-ERB bind to the Rev-erb 
promoter, but not the Rev-erb promoter, and this difference hints that REV-ERB and 
REV-ERB are not equal in the core clock machinery. Indeed, genetic deletion of Rev-
erb has a more significant effect on circadian rhythms compared with genetic deletion 
of Rev-erb(Cho et al., 2012). To compare the roles of REV-ERB and REV-ERB in 
the liver, I plan to use the conditional null models for both genes, and carefully examine 
gene expression changes in response to liver-specific deletion of REV-ERB and/or 
REV-ERB. In Chapter 3 and 4, I tested the function of REV-ERB and REV-ERB on 
circadian rhythms and hepatic metabolism using germline deletion of Rev-erb or an 
adenovirus that encodes shRNA targeting Rev-erb. But I cannot accurately compare the 
roles of REV-ERB and REV-ERB by using two different methods, not to mention that 
each method has major drawbacks. Germline deletion leads to complete loss of Rev-erb 
throughout the body, and adenovirus encoding shRNA has off-target effects and induces 
immune response and liver toxicity. Aware of these drawbacks, I also hope to validate all 
my previous findings using the conditional null models for Rev-erbs.  
 
Although REV-ERB and REV-ERB may share the same genomic binding and gene 
targets, they could respond differently to cell signaling and have different physiological 
roles. For instance, REV-ERB is subject to post-translational regulation by GSK3 and 
E3 ubiquitin ligase ARF-BP/PAM. GSK3 phosphorylates serine 55 and 59 in the N-
terminal domain of REV-ERB, and protects REV-ERB from ubiquitination and 
degradation. The GSK3 phosphorylation motif is not conserved in REV-ERB. This 
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raises two possibilities. First, loss of REV-ERB affects a subset of metabolic genes, and 
REV-ERB protects the rest metabolic pathways and the circadian clock. This could be 
addressed by carefully comparing the Rev-erb conditional null models discussed earlier. 
Second, REV-ERB, but not REV-ERB, receives environmental signals and adjusts the 
liver clock. This is supported by a previous finding in the lab that serum shock induces 
REV-ERB degradation through ARF-BP/PAM.  
 
In summary, I would like to address the non-redundant functions of REV-ERB and 
REV-ERB in liver by comparing gene expression in response to loss of either REV-
ERB, and by studying how REV-ERBs are differentially regulated in response to 
systematic signals, such as insulin, glucocorticoid and serum shock. I also plan to test if 
the redundancy of REV-ERB and REV-ERB observed in liver also exists in other 
major metabolic organs, such as adipose tissues and muscle. 
 
 
5.2e HDAC3 in Circadian Rhythms and Others  
HDAC inhibitors are widely used in clinical trials and treatments in psychiatry, 
neurology, cancer and inflammatory diseases, and many of them inhibit HDAC3 activity. 
Therefore it is important to have a thorough understanding of different physiological 
functions of HDAC3. This knowledge will help predict and reduce the side effects of 
HDAC inhibitors, and will help uncover new applications for them.  
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In Chapter 3 and Chapter 4, I reported that REV-ERBs recruit HDAC3 to repress clock 
genes such as Bmal1 and Npas2. Do REV-ERBs recruit HDAC3 to repress clock genes 
in the central clock and other peripheral clocks? Is HDAC3 required for normal circadian 
rhythms? To answer the first question, I will examine HDAC3 recruitment at the Bmal1 
and Npas2 genes in the SCN and other peripheral tissues, such as fat and muscle. To 
determine if HDAC3 is required for normal circadian rhythms, I will cross the HDAC3
fl/fl
 
mice to Rosa26-Cre-ER mice (these mice display tamoxifen-inducible Cre activity in all 
tissue types), and induce HDAC3 deletion in adult mice. We can then assess the circadian 
rhythms in these mice by measuring clock gene expression in the SCN and many 
peripheral tissues, such as liver, muscle, and fat, and by measuring food intake and 
locomoter activity in regular light dark cycles and in constant darkness. An alternative is 
to delete HDAC3 in mouse embryonic fibroblasts and measure the oscillation of clock 
genes after serum shock.  
 
In Chapter 3, I reported a surprising overlapping between REV-ERB and HDAC3 
genomic binding, and showed that recruitment of HDAC3 at many sites are REV-ERB 
dependent. But it is unlikely that HDAC3 is completely ‘enslaved’ by REV-ERBs in 
other tissues. Indeed, HDAC3 may not even be recruited by nuclear receptors, as shown 
in macrophages (Mullican et al., 2011). In the future, I hope to explore HDAC3 functions 
in other tissues and understand how HDAC3 is recruited in these tissues. I will focus on 
metabolic organs, such as muscle, heart and adipose tissues, and begin with HDAC3 
ChIP-seq. ChIP-seq may reveal HDAC3 targets that account for the metabolic disorders 
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induced by HDAC3 deletion in these tissues (Sun et al., 2011), and motif analysis of 
HDAC3 cistromes helps identify transcription factors that mediate HDAC3 recruitment. 
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Figure 5.1 REV-ERB and HDAC3 Recruitment in Response to Food Intake. 
A. Wild type were fasted and refed as indicated in regular light/dark cycles. The gray 
area indicates the period without food. Liver tissues were collected at ZT22 and ZT10/34 
as indicated by the arrow.  
B. C. REV-ERB (B) and HDAC3 (C) recruitment in livers collected in A were 
interrogated by ChIP-PCR. Values are mean ± s.e.m (n=4-5). 
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Figure 5.2 Loss of HDAC3 Binding Rhythm in Jet-lag Mice.  
A. The chronic jet-lag treatment. Each week, the light/dark onset time was advanced by 8 
hours; 3 days later, it was switched back until next week.   
B. Bmal1, Rev-erb and Rev-erb expression was measured in livers harvested at ZT10 
and ZT22 from 14 week old jet-lag mice or mice housed under regulator light/dark cycles 
(WT). Values are mean ± s.e.m (n=3). 
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C. HDAC3 (C) recruitment in livers harvested at ZT10 and ZT22 from 14 week old jet-
lag mice mice housed under regulator light/dark cycles (WT). Values are mean ± s.e.m 
(n=3). 
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Figure 5.3 Loss of HDAC3 Binding Rhythm in Cry DKO Mice.  
A. Bmal1, Rev-erb and Rev-erb expression was measured in livers harvested at ZT10 
and ZT22 from 14 week old Cry DKO mice. Values are mean ± s.e.m (n=3). 
B. C. Rev-erb (B) and HDAC3 (C) recruitment in livers harvested at ZT10 and ZT22 
from 14 week old Cry DKO mice. Values are mean ± s.e.m (n=3). 
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